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INTRODUCTION 
The overall aim of the studies in this thesis was to 
further characterize the regulation of androgen action at the 
biological and biochemical level· In general, androgen action 
is mediated via the following steps: androgen enter the cell 
and may or may not be metabolized to active compounts, andro-
genic compounds are bound to androgen specific receptors. The 
steroid-receptor complex is concentrated in the nucleus where 
it interacts with acceptor sites of the chromatin to stimu-
late ribonucleic acid (RNA) polymerase activities, an 
increase in specific mRNA's, and ultimately an increase in 
the synthesis of specific proteins as well as growth of the 
organ. The end result of androgen action can be regulated via 
genetic or metabolic factors, alterations in receptor bind-
ing, or changes in steroid-receptor interactions with 
chromatin. 
These studies used a variety of protocols to elucidate 
various points of androgen regulation. These included a novel 
progestin 6a-methylprogesterone (6MP), with multiple effects 
on androgen action, tissues with different steroid metabolic 
patterns, isoenzymes under different androgen-genetic 
control, species of mice with different patterns of androgen 
responses and a mouse with previously uncharacterized defects 
in androgen response. 
Mouse kidney was found to be a particularly useful target 
organ for studies designed to elucidate the fine points of 
androgen regulation. The general mechanism of androgen action 
in mouse kidney is similar to that described for classical 
androgen target tissues such as prostate (Mainwaring et al. 
1977). However, the presence of some unique characteristics 
give the mouse kidney some advantages over prostate for the 
study of the regulation of androgen action. These will be 
described in chapter 1-1. We used the kidney as the major 
target organ to further elucidate several aspects of the 
regulation of androgen action (Bardin et al. 1978): 
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1. It is known that steroids may exert several classes of 
biological effects· They may be stimulatory by themselves or 
they may inhibit or enhance the effects of other steroids. 
The binding of 6MP in mouse kidney was used to further 
elucidate how these various effects are mediated. The 
progestins medroxyprogesterone acetate (MPA) and cyproterone 
acetate (CA) had previously been shown to mimic and/or modify 
androgen action (Mowszowikz et al. 1974 and Gupta et al. 
1978) in mouse kidney via binding to the androgen receptor 
(Bullock et al. 1978). The androgenic response to 6MP was 
found in normal female but not in Tfm/Y mice which lack 
effective androgen receptors (Bullock and Bardin, 1974). 
There were other findings, however, that could not be 
explained by simple binding to the androgen receptor. The in 
vivo administration of unlabeled steroids, testosterone (T), 
6MP, MPA, CA, and dexamethasone (DEX), prior to 3H-6MP 
enhanced the nuclear uptake of radioactivity in kidney but 
not prostate seminal vesicle nuclei. Radioactivity was 
concentrated in kidney nuclei in Tfm/Y mice despite the fact 
that they lack effective androgen receptors and do not 
respond to the androgenic effects of 6MP (Brown et al. 1981a 
+ b). These data were all evidence for the specific binding 
of 6MP to another receptor in mouse kidney besides the andro-
gen receptor. The present study (see Ch. IV) was to 
characterize this 'other' receptor which was shown to be a 
glucocorticoid receptor. Although the androgenic progestin 
MPA had not shown similar binding characteristics and a 
glucocorticoid receptor had not been previously reported for 
the mouse kidney, the finding did correlate with the report 
that 6MP had glucocorticoid-like effects on rat thymus and 
liver (DiSorbo et al. 1977). 
2. The biological effects of a steroid are determined not 
only by the presence of specific receptors within a tissue 
but also by the form of the steroid, parent compound or a 
metabolite, that is available for binding (Bullock and 
Bardin, 1980). 6MP was used to further characterize the role 
of metabolism in determining the intranuclear, and thus the 
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biologically active form of the steroid. Following the intra-
venous administration of 'H-6MP specific uptake of the 
steroid as well as a more polar metabolite was found in 
kidney nuclei. In prostate-seminal vesicle nuclei, however, 
predominantly 6MP and little of the metabolite were present 
(Brown et al. 1981a).These results suggested that enzymes 
and/or binding proteins differed in the two tissues and were 
acting to regulate the nuclear steroid. In the present study 
(See Ch.V) the tentative identification of the metabolite as 
20e-hydroxy-6MP was confirmed and the activity of 
ZOa-hydroxy-steroid dehydrogenase (20-HSD) in determining the 
presence or absence of the metabolite in the two tissues was 
evaluated. Enzyme activity in prostate-seminal vesicle was 
low compared to the activity present in kidney cytosol. It 
was thus apparent that intracellular metabolism was important 
in establishing the presence or absence of the metabolite in 
the nucleus. This documented another example of the 
importance of intracellular metabolism in determining the 
intranuclear steroid and thus the potential biological 
effects a steroid could exert within a tissue. 
3. Androgenic effects are regulated not only by the 
steroid receptor and the intracellular steroid available for 
binding but also by the make up of chromatin which will 
determine which genes will be activated by the steroid-
receptor complex for transcription (Liao et al. 1983 and 
Bardin et al. 1976). Two well characterized androgenic 
responses of the kidney in the common laboratory mouse, Mus 
musculus, are renal weight and b-glucuronidase activity 
(Bardin et al. 1978). In an preliminary evaluation of a wild 
species of mouse, Mus caroli, it was found that not only was 
there no difference in these end points between males and 
females but that they were also not stimulated by 
administration of androgens. It was unlikely that these mice 
had a bodywide deficiency of androgen receptors since the 
males were fully developed and fertile (Swank et al, 1978). 
There was a possibility, however, that, in contrast to Mus 
musculus, androgen receptors were not expressed in kidney of 
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Mus caroli. An alternative explanation was that renal andro­
gen receptors were present but that renal androgen responsive 
genes differed in the two mouse species. The present study 
(see Ch. VII) docunented the presence of renal androgen 
receptors in Mus caroli with essentially the same concentrat­
ion and affinity for testosterone as in Mus musculus. 
This correlated with the subsequent demonstration that Mus 
caroli kindneys were indeed androgen responsive when the 
appropriate endpoint was used. Ornithine decarboxylase (ODC), 
an androgen responsive renal enzyme in Mus musculus, also was 
induced by androgen in Mus caroli. This then is an example of 
the role of chromatin in regulating androgen response in the 
same tissue of different but closely related species. 
4. Androgen action is also regulated by the ability of the 
steroid-receptor complex to differentially interact with a 
specific gene(s) within a family (Заппе et al. 1983). This 
can act to determine not only the amount but also the bio­
chemical properties of specific enzyme activities as assayed 
in vitro. ODC is a rapidly turning over enzyme that, in mouse 
kidney, increases markedly in activity following androgen 
stimulation. In the present study (See Ch. VI) the androgen 
induction of ODC was used as an example of how androgen 
action can alter the half life and heat sensitivity of enzyme 
activity in basal as opposed to induced states. Basal levels 
of renal ODC activity were shown to consist of two forms of 
activity which differed in half life and heat sensitivity. 
Androgens induced primarily the heat sensitive form and 
greatly increased the half-life of ODC activity. These 
parameters of androgen inducible ODC activity had not been 
suspected previously. The biological demonstration of two 
forms of ODC activity correlates with reports from some 
laboratories of the presence of at least two different ODC 
genes. The two forms of ODC activity identified in this study 
provide the tools for future studies designed to correlate 
the regulation of androgen action as manifested at the 
molecular and biological level. 
16 
5. For androgen action to be ultimately expressed, a com-
plex series of events, from binding to the specific receptor 
to the final processing of specific proteins, must occur in a 
normal manner. Several biological examples of diminished 
androgen action have been described in humans and linked to 
several different defects involved in the normal nuclear 
activation by androgens (Meyer et al. 1975; Kaufman et al. 
1976; Amrhein et al. 1976). A useful laboratory tool for 
characterizing one form of defect and for studying the regu-
lation of androgen action has been the male pseudoherm-
aphrodite, Tfm/Y mouse (Danne et al. 1976; Bullock et al. 
1974; Bardin et al. 1973). This mouse has a bodywide absence 
of effective androgen receptors and represents an animal 
model of the syndrome of Testicular Feminization. The defect 
is due to a marked decrease in the number of androgen 
receptors, and those that are present have biochemical 
characteristics of a minor form of the normal receptor. The 
report of a second mutation resulting in a male pseudoherm-
aphroditic mouse offered the potential of characterizing a 
new animal model with second defect in androgen action. The 
present paper (See Ch. VIII) describes the characterization 
of the defect that resulted in androgen insenaitivity in 
another colony of pseudohermaphroditic mice, TfmL/Y. Again 
there was a marked decrease in the number of androgen 
receptors present but those that were present have the bio-
chemical characteristics of those in normal mice. This then 
adds a third animal model to the two already present, the 
Tfm/Y mouse and the Tfm rat, that represent important tools 
for future studies of the regulation of gene expression at 
the genomic level. 
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CHAPTER 1. Mouse kidney as an androgen target organ 
1. Introduction 
The androgenic activity of testosterone and its 5a-meta-
bolite, dihydrotestosterone (DHT) is classically defined as 
the growth-promoting effect on the male reproductive tract. 
By contrast, the effect of androgen on nitrogen balance and 
body weight results from stimulation of protein synthesis in 
tissues such as liver, kidney, bone and muscle which comprise 
a major portion of body mass. 
Both types of response involve an increase in protein syn-
thesis. Tissues of the reproductive tract are dependent upon 
androgens for their differentiation and manifest cell divis-
ion as part of the androgenic response. Tissues having an 
anabolic response are not dependent upon androgens for 
differentiation and respond with hypertrophy but not hyper-
plasia to androgen stimulation. 
Reviews by Mainwaring (1977) and Bardin et al. (1981b) 
have emphasized that the early effects of testosterone on the 
mouse kidney, an organ thought to reflect anabolic responses, 
are similar to those in the male reproductive tract. In both 
tissues, the following events occur in the process of andro-
gen- induced cell activating: androgens bind to a specific 
cytoplasmic receptor which is transferred to the nucleus of 
the cell; there are early increases in RNA polymerase and 
chromatin template activities; activating of specific genes 
results in the synthesis of specific mRNA's and ultimately 
their respective proteins. 
This theory of intracellular action of steroids has 
recently been guestioned by King and Green (1984) and 
Weishons et al. (1984). In their studies in which monoclonal 
antibodies against receptors are used to investigate the sub-
cellular distribution of unfilled estrogen receptors, it is 
concluded that cytosolic estrogen receptors represent an 
extraction artefact due to the processing of tissues in the 
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laboratory. 
Review article by Gase and Baulleu (1986) discuss the 
mechanism of action of steroid hormone· Several immunohlsto-
chemical studies were published by different groups. Evidence 
for a nuclear receptor In absence of hormone seems to be true 
for estradiol receptor and progesterone receptor. Glucocorti-
coid receptor may not be all nuclear and little is known 
about androgen receptor since there is no antibody available 
yet. 
Even if it is eventually accepted that cytosolic estrogen 
receptors represent an extraction artefact and that all 
estrogen receptors are intranuclear in vivo, cytoplasmic data 
will still be valid as a reflection of a class of intra-
nuclear receptors probably not containing steroid, that are 
bound with such a low affinity to the nuclear binding sites, 
that they are soluble during homogenization. 
There are also some differences in androgen action between 
tissues; androgens do not stimulate DNA synthesis and are not 
converted to DHT in kidney as is the case in the reproductive 
tract (Bardin et al. 1978). 
The above considerations indicate that information concerning 
the mechanism of androgen action can be obtained from many 
tissues besides the classical sex-organs. The mouse kidney is 
particularly useful for this purpose due to the following 
reasons: 
a) the lack of 5-alpha-reductase activity allows study of the 
testosterone-androgen receptor complex without concomitant 
steroid metabolism, thus simplifying the model needed to 
explain androgen action; 
b) the absence of androgen induced DNA-synthesis permits the 
study of cellular hypertrophy independent of hyperplasia. 
Thus cell numbers do not increase during induction. 
c) the synthesis of several renal proteins is stimulated 
many-fold by testosterone and other androgens, making 
these proteins particularly useful markers of gene 
activity; 
d) there are several individual genes in the mouse that 
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influence the magnitude of specific androgen responses. 
The use of different genetic variants at these loci 
facilitates the study of the individual steps of 
androgeninduced gene activitation. 
2. Biosynthesis of androgens 
The physiologic androgens are classified as C-19 steroid 
hormones. The most potent androgens are testosterone and its 
5a-reduced metabolite, Sa-dihydrotestosterone (DHT). These 
steroids are synthesized in the testis, the ovary and the 
adrenal along the metabolic pathway shown in Fig. 1. 
The synthesis of all steroid hormones starts with 
cholesterol. The side chain is cleaved at C-21-22 to give 
pregnenolone, a C-21 steroid. Following the delta-5 pathway, 
pregnenolone is metabolized to 17a-hydroxypregnenolone and 
then to dehydroepiandrosterone (DHEA), a C-17 steroid. DHEA 
acts as a precursor, via peripheral metabolism, to a nunber 
of 17-ketosteroids such as androsterone and etiocholanolone 
which are weak androgens. Within the testis, DHEA is convert-
ed to delta-4-androstenedione which is then reduced to form 
testosterone. In peripheral tissues the 4,5 double bound may 
be reduced to form either 5a- or Sb-derivatives. These 
compounds differ greatly in their spatial configuration and 
androgenic activity. The SS-derivatives are not androgenic, 
whereas the 5a-derivative, DHT, is the principal androgenic 
hormone in a variety of target tissues. 
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CONVERSION OF CHOLESTEROL TO ANDROGEN 
CHOLESTEBCX. 
I 
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Fiq. ι The fortaation of cholesterol to testosterone involves 
enzyaes which induce hydroxy1 groups (hydroxylase), 
remove hydroicyl groups (dehydrogenase), transfer the 
double band from the 5-6 position to the 4-5 posit ion 
(isomerase) and desmotase cleavage of the side chain. 
The 17-ketasteroids ere characterized by an oxygen 
atom In the 17 posit ion. The 17-ketone may be reduced 
to a 178-hydroxyl to form testosterone by 17в-Пу<ігоху-
3teгоid dehydrogenase. The reduction of the 4-5 double 
band by 5a-reductase converts testosterone to 5a-
dihydrotestosterone, which is the p r i n c i p a l androgenic 
hormone in a variety of target tissues and is formed 
within the target tissue i t s e l f . 
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3. Mechanism of androgen action in mouse kidney 
A. Androgen receptor 
The understanding of the mechanism of steroid action began 
with the demonstration by Jensen and colleagues of the 
selective concentration and retention of estradiol by the 
target tissues uterus and vagina. They subsequently demon­
strated binding of estradiol to a specific receptor protein 
(Jensen and DeSombre, review 1972). The introduction of 
sucrose gradient centrifugation in 1966 by Toft and Gorski 
provided the first of many methods developed to characterize 
the hormone-receptor complex. From these beginnings the study 
of steroid hormone receptors rapidly expanded until now it is 
accepted that a universal receptor mechanism mediates the 
action of all classes of steroids (Ringold, review 19Э5). It 
requires the presence of 'receptor' proteins, specific for 
each class of steroid hormone, in the specific steroid 
responsive cells. These receptors have been shown to share a 
variety of characteristics including high affinity and low 
capacity binding of the appropriate steroids and typical 
sedimentation rates of steroid-receptor complexes in sucrose 
gradients depending on the buffer and the method of prepara­
tion of the steroid receptor-complex. The steroid-receptor 
complexes bind to specific acceptor sites on chromatin induc­
ing RNA polymerase activity, the transcription of specific 
genes and ultimately the synthesis of specific proteins. 
Because steroids exert their effects directly through effects 
in the nucleus it is recognized that the intranuclear form of 
the steroid is the biologically active one. 
Early studies of the mechanism of androgen action revealed 
the selective retention of not the parent compound, testoste­
rone (T), but DHT by prostate cell nuclei in vivo (Bruchovsky 
and Wilson, 1968). Subsequently the existence of DHT-receptor 
complexes was reported (Mainwaring 1977, review). From these 
and subsequent reports it was recognized that it was not T, 
but the metabolite DHT that was the active intranuclear 
androgen in male accessory sex organs. 
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However, when our laboratory started to study androgen 
action using mouse kidney as a target organ different results 
were obtained. When ^H-T
 Was administered to mice it was 
found that ^H-T and not ^H-OHT was concentrated in kidney 
nuclei (Bullock and Bardin, 1975b). If, however, Ή-ΟΗΤ was 
given, ^H-OHT was concentrated in renal nuclei. 
An androgen specific receptor, sedimenting as a 3.6S macro-
molecule could be extracted from nuclei labelled in vivo. 
When cytosol was incubated with ^H-steroid at 1*C, an andro­
gen binding protein sedimenting in the 7.9S range was demon­
strated (Bullock and Bardin, 1974). Competition studies, in 
which DHT displaced ^H-l binding and visa versa, were used to 
demonstrate that Τ and DHT were binding to the same protein. 
A variety of assays were used to demonstrate that this binder 
had the characteristics of an androgen receptor (Bullock et 
al.l975d). The receptor was specific for androgens and did 
not bind 'Η-estradiol, -3a or -3b-andro3tanediols, -andro-
stenedione, or -progesterone. Although Ή-dexamethasone was 
also bound by a macromolecule sedimenting in the same region 
as that for testosterone, neither steroid was able to 
displace the other when added in excess. It was of interest 
to note that the addition of nonradioactive glucocorticoids 
such as Cortisol and dexamethasone tended to increase the 
amount of ^n-testosterone binding. These findings became 
important several years later for the studies using 6a-
methylprogesterone (see chapter III). The receptor bound ^H-T 
with an affinity in the nanomolar range while the affinity 
for DHT was slightly less (Bullock and Bardin, 1974). Despite 
the slightly lower binding affinity for DHT the steroid was a 
more potent androgen than Τ in mouse kidney (Bardin et al. 
1973). Through out these studies, no difference in binding or 
nuclear uptake was noticed between female or castrated male 
mice (Bullock and Bardin, 1974). 
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В. Androgen metabolism 
Many natural steroid hormones enter target cells, bind to 
receptors and are concentrated in nuclei without metabolic 
conversion. However, as mentioned above, Τ acts in the 
prostate, other accessory sex tissues, and skin, only after 
conversion to DHT (Wilson et al. 1981). In other tissues, 
such as kidney, brain, pituitary, submaxillary gland, testes 
and muscle, Τ itself has been found to be the intranuclear 
steroid (Mainwaring, 1977; Bardin and Catterall, 1981). It 
was apparent that the endogenous steroid responsible for 
initiating androgen action varies between tissues. This is 
regulated by the presence or absence of 5a-reductase activity 
which reduces Τ to 5a-DHT. It is thus apparent that intracel­
lular metabolism of steroids plays an important role in 
determining the active intranuclear steroid. 
Recognizing this importance, our laboratory conducted a 
series of experiments to characterize the metabolism of Τ and 
DHT in mouse kidney. Incubation of kidney slices with ^H-T 
for 2 hours at 1*C resulted in 87?» of the radioactivity being 
recovered as unmetaboiized Эц-Т (Bullock and Bardin, 1974). 
In contrast, when ^H-DHT was used as substrate 65% of the 
substrate appeared as 5H-5a-androstanediols. There is thus 
little 5a-reductase activity but a very active 3-keto 
reductase in mouse kidney. This means that steady state con­
centrations of DHT cannot be maintained for long periods of 
time during in vitro binding studies. This problem can be 
avoided, however, if Τ is used. 
Additional in vivo studies (Bullock and Bardin, 1975b) 
gave further examples of the importance of intracellular 
metabolism in determining the active intranuclear androgen. 
Following the iv administration of ^H-delta-^-androstenedione 
to mice, ^H-T was concentrated by renal nuclei. -Ή-ΟΗΤ was 
the intranuclear steroid, however, following injection of 
^Н-За- or 3b-androstanediol. It is thus apparent that 
androstenedione and the -diols are not androgenic directly 
but only after the appropriate metabolism. The oxidation of 
Jb-diol to DHT in mouse kidney is in contrast to what has 
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been reported for rat prostate in organ culture (Robel et 
al. 1971). In this system, 3b-diol was not metabolized to DHT 
but may have its own extranuclear site of action. 
4. Biological response of mouse kidney to androgen. 
A. Androgen stimulation of transcriptional events. 
Results from studies using a variety of steroid responsive 
systems indicate that steroid hormones regulate the target 
cell response primarily by influencing RNA synthesis (Ringold 
19β5). Janne et al (1976) studied the early changes in trans­
criptional events in mouse kidney in response to a single 
subcutaneous injection of T. Both RNA polymerase I and II 
activities, as evaluated in isolated nuclei, increased in a 
biphasic manner although the time course of response was 
different for each enzyme. The initial peak of activity for 
both polymerases occurred within 1-2 hours. They returned to 
control values by 2-4 hours and peaked again at 20 and 12 
hours for polymerase I and II respectively. The initial fall 
in RNA polymerase II activity (1-2 hour) occurred at a time 
when there was still a significant amount of Τ present in 
kidney nuclei. Nevertheless, a second peak of polymerase 
activity did occur, which indicates new protein synthesis. A 
second dose of Τ given at 4 hours, when template activity had 
returned to control values, had little effect. This is 
similar to the insensitivity of the rat uterus to repeated 
doses of estrogen (Katzenellenbogen 1973). Androgens did not 
induce a change in any of these transcriptional events in 
androgen insensitive Tfm/Y mice (Lin et al. 197Θ). 
Similar patterns of transcriptional response have been 
reported by others for androgen stimulation of the rat 
prostate and estrogen stimulation of the uterus (Mainwanng 
et al. 1971; Classer et al. 1972). Thus, androgen stimulation 
of transcriptional events in mouse kidney is similar to that 
induced generally by sex hormones in accessory sex tissue and 
requires functional androgen receptors· 
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Although RNA synthesis is known to increase, there is 
little known about transcriptional processes following 
prolonged steroid treatment. 
It is of interest to note that tissues which concentrate Τ 
in the nucleus (kidney, muscle) respond to androgen with an 
increase of RNA and protein without significant DNA synthesis 
(Buresova and Gutmann, 1971). By contrast, those tissues 
which concentrate DHT (prostate, seminal vesicle) are those 
in which DNA synthesis is a component of the androgen induced 
response (Williams-Ashman and Reddi, 1971). 
B. B-glucuronidase. 
Androgen stimulation of a number of specific kidney 
proteins has been reported as summarized in table 1. 
(Reviewed by Bardin et al. 197Θ). 
Table 1. Androgen responsive proteins of mouse kidney. 
Glutamic-pyruvic transaminase Arginase 
Glutamic-oxaloacetate Digalactosylceramide 
transaminase Esterases 
Glutamate dehydrogenase Alcohol dehydrogenase 
D-amino acid oxidase 3-keto-reductase 
θ-glucuronidase T-proteins 
Of the many androgen responsive renal proteins, B-glucuro­
nidase is the best studied especially by the group of 
Paigen. Intracellular activity is regulated by genes control­
ling steroid structure, intracellular processing, excretion 
rates as well as the response to androgens (Paigen, 1979). 
These have been characterized using inbred strains of mice 
carrying different alleles to these genes. The androgenrecep-
tor complex is required for activation of the B-glucuronidase 
gene. Although the protein comprises only 0.3% of total 
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kidney protein when fully induced (Paigen et al. 1975) its 
usefulness for the study of hormone action is derived from 
the fact that androgens produce a 20-50 fold increase in 
enzyme activity. However, following androgen stimulation of 
B-glucuronidase activity there is not only the normal enzyme 
degredation going on but androgen enhancement of enzyme 
excretion into urine. As a result, studies of glucuronidase 
mftNA and enzyme synthesis give better estimates of androgen 
stimulation of gene expression than measurements of tissue 
enzyme activity. In recent years moleculair studies revealed 
direct correlation of primary gene structure with the pheno-
typic expression of various mutant strains by cloning a cDNA 
sequence complementary to mouse, B-glucuronidase mRNA 
(Catterai and Leary, 1983; Palmer et al. 19Θ3). 
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С. Ornithine Decarboxylase (ODC). 
In 1677 the first polyamine, spermine, was discovered in 
hunan semen by A. Leeuwenhoek. Since then significant con­
centrations of various poiyamines have been found in many 
prokaryotic and eukaryotic cells. The poiyamines histamine, 
putrescine, spermidine and spermine are normal constituents 
of most mammalian tissues. While histamine has been studied 
since the beginning of this century, efforts have focused on 
the other poiyamines only in the last ten years. This is 
despite the fact that their presence in h unan semen has been 
known for more than a century. 
Although the physiologic function of these amines is still 
not understood at the molecular level, recent studies have 
shown their concentration to be closely regulated by the cell 
according to the state of growth (Heby et al. 1986). Findings 
that poiyamines in low concentrations stimulate growth of 
bacteria (Tabar et al. 1961) and a mammalian cell line (Ham 
1964) led to subsequent studies demonstrating that poiyamines 
participate in nearly all aspects of DNA replication (Tabor 
and Tabor ,1976) and RNA synthesis (Janne et al. 1975). 
ODC catalyzes the first step in the biosynthesis of 
putrescine, spermidine and spermine, the three major poiy­
amines of mammalian cells (Pegg and McCann, 1982). Of the 
four enzymes involved in mammalian polyamine biosynthesis, 
this pyridoxal phosphate-dependent enzyme has the lowest 
basal activity in vivo and is regarded as the rate limiting 
enzyme in this pathway. Ornithine is available as a precursor 
from plasma. It can also be formed within the cell by the 
action of arginase (fig. 2). 
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PATHWAY OF POLYAMINE SYNTHESIS 
Arginine 
-NH-C 
-ureum NH2 
H2N-Ç- H-CH2-CH2-CH2-CH-COO-
τ 
• NH2 
Ornithine 
H2N - CH2 - CH2 - CH2 - CH - COOH 
ornithine I ^ ^
 N H 
decarboxylase I ' * 
Putrescine 
H2N - CH2 - CH2 - CH2 - CH2 - NH2 
spermidine I 
synthase 
Spermidine 
H2N-CH2-CH2-CH2-NHCH2-CH2-CH2-CH2-NK2 
spermine 
synthase 
Spennine 
H2N - CH2 - CH2 - CH2 - NHCH2 - CH2 - CH2 - CH2 - NH - CH2 - CH2 - CH2 - NH2 
Fig. 2 ODC provide the immediate precursor, putrescine from 
the parent aminoacids. Formation of spermidine from 
putrescine is catalyzed by spermidine synthase and 
requires the addition of an aminopropyl group to the 
putrescine molecule; an additional aminopropyl group 
Is utilized in the subsequent conversion of spermidine 
to spermine. This reaction is catalyzed by spermine 
synthase. 
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ODC is present in very small amounts in quiescent cells. 
Its activity can be increased many fold within a few hours by 
exposure to many trophic stimuli like hormones, drugs, tissue 
regeneration, and growth factors (McCann 1980). 
The androgen reponsiveness of ODC activity in mouse kidney 
has been known for at least a decade but only recently it has 
received much attention when our laboratory began to use ODC 
as an endpoint of androgen action. Although ODC response in 
general is ubiquitous in nature, the specificity of androgen 
stimulation in kidney was docunentated (Bullock, 1983). The 
response required a functional androgen receptor and was 
specific for androgens. Activity declined to female levels 
after castration of males and increased in both sexes to 
levels higher than those in any other mammalian tissue in 
response to testosterone treatment. The response required a 
functional androgen receptor and was specific for androgens. 
Neither acute (24 hour) nor chronic (5 days) treatment with 
T, or androgenic progestins, had any effect on renal ODC 
activity in androgen-insensitive Tfm/Y mice, which lack 
effective androgen receptors. The anti-endrogens cyproterone 
acetate and flutamide did not stimulate ODC activity nor did 
the non-androgenic steroids progesterone, 17a-0H-6MP, 
ethynylestradiol, and Cortisol (Bullock, 1983). This is 
despite the fact that the mouse kidney contains estrogen 
(Bullock and Bardin, 1975a) and glucocorticoid receptors 
(Bullock and Bardin, 1974; Chapter IV)) for the latter 2 
steroids. 
A single dose of testosterone induces a significant 
increase in renal ODC activity within 6 hours with a maximum 
at 12 hours. Elevated activity can be maintained for days 
with continued androgen treatment. The duration of nuclear 
receptor residence rather than the initial nuclear receptor 
concentration appeared to be an important regulatory factor 
determining the degree of ODC response. The testosterone 
stimulated renal ODC response in C57BL/6J mice was approx-
imately 50% of that seen in DBA/23 mice (Bullock 1983). This 
suggests that genetic factors may also be involved in the 
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regulation of the androgen responsiveness of this enzyme. 
The increase in renal ODC activity stimulated by testo­
sterone comes about via several mechanisms. In recent studies 
cDNA for ODC has been used to document an increase in ODC 
mRNA (Kontula et al. 1984). Antibodies have been synthesized 
(Sjoerdsma 1981) to ODC and Зн-difluoromethyl ornithine, an 
inhibitor of ODC activity which binds irreversibly to ODC, 
have been used to show that there is an increase in the 
absolute number of ODC molecules (Seely and Pegg, 1983; Seely 
et al. 1982). Androgen also stimulates a decrease in the rate 
of ODC degredation. This latter mechanism cannot account for 
the entire increase in enzyme activity, however. While there 
was a 4-fold increase in ODC half life in the BALB/c mice 
there was a 50-fold increase in enzyme activity. 
The increase in ODC activity is localized primarily (90й) 
in the cortex, the androgen responsive portion of the kidney 
(Bullock, 1983). Autoradiography showed that ODC was present 
in all renal cell types but the highest content was in the 
proximal convoluted tubules, followed by the distal tubules 
and the collecting ducts. The majority of the enzyme was 
located in the cytoplasm but about 10-15% was present in the 
nuclei of the cells of the proximal and distal convoluted 
tubules (Zagon et al. 1984). Proximal convoluted cells also 
respond to androgen stimulation with hypertrophy and are the 
site of androgen stimulated B-glucuronidase (Bardin et al. 
1978). 
Interestingly, both estrogen and corticosterone stimulate 
ODC activity in rat kidney although not to the extent that 
androgens do in the mouse (Nawata et al. 1980; Brandt et al. 
1972). 
ODC activity in mouse kidney thus has several characteris­
tics that make it an useful endpoint in the study of the 
mechanism of androgen regulation at both the physiologic as 
well as the molecular level. These include the requirement of 
a functional androgen receptor, the specificity of response 
for androgens, the response to physiological concentration of 
androgens, the rapidity and magnitude of change of activity. 
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5. Androgen insensitivity (testicular feminization, Tfm) 
Testicular feminization (Tfm), a syndrome characterized by 
inherited end organ insensitivity to androgens and lack of 
androgen dependent differentiation was first described in man 
(Morris, 1953) and demonstrated in rats (Bardin et al. 1970). 
An inherited syndrome of androgen insensitivity in the 
mouse was initially described by Lyon and Hawkes, 1970. 
Affected animals (Tfm/Y) lack prostate and seminal vesicles 
due to end organ insensitivity in utero. In earlier studies 
of androgen insensitivity in Tfm rats by Bullock and Bardin 
(1973) preputial gland nuclei were unable to retain Ή-ΟΗΤ. 
This was associated with greatly decreased concentration of 
androgen receptor (Bullock and Bardin, 1972). Similar studies 
in Tfm/Y mice revealed that this strain is unable to concen­
trate 5H-testosterone or 5H-0HT (Bullock and Bardin, 1974). 
The relative absence of cytosol receptors has also been used 
to explain steroid insensitivity in several other tissues 
(Bullock and Bardin, 1977). 
Tfm/Y mice have been and continue to be a valuable tool in 
our studies of androgen action to distinguish between 
specific and nonspecific androgen receptor mediated and non­
receptor mediated responses to steroids and to characterize 
the role of the androgen receptor mediating androgen action. 
The Tfm/Y mouse, however, represents only one mutation. 
Since androgen insensitivity in man has been linked to a 
variety of defects involving enzymatic, receptor and post 
receptor events the opportunity to study a second mutation in 
a laboratory animal would be advantageous. 
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CHAPTER II. Effects of progestins on mouse kidney 
1. Introduction 
Although a sex steroid is usually classified according to 
its major action, namely androgenic, estrogenic or progesta-
genic, it may also stimulate or affect responses induced by 
other steroid classes. The androgenic and anti-androgenic 
actions of progestins have been known for some time. More 
recently the synandrogenic effect of progestins, or the 
potentation of androgen action, has been described. These 
various effects of progestins depend on the steroid and the 
end point being tested. In some cases it also depends on the 
strain of mouse being used (Brown et al. 1981b). 
2. Biological effects of progestins 
A. Androgenic effects 
The progestins, MPA, megestrol acetate (MegAc), 17a-hydr-
oxyprogesterone acetate, and 6MP induce dose dependent 
increases in androgenic responses in female mice as shown by 
an increase in the activity of renal θ-glucuronidase and 
alcohol dehydrogenase (ADH) activity. The progestins also 
affected the submaxillarly gland and epidermal growth factor 
(Bullock et al. 1975c). In contrast, progesterone and proge­
sterone caproate were ineffective. Androgenic responses could 
not be induced by progestins in the androgen insensitive 
Tftn/Y mouse (Mowszowicz et al. 1974). 
B. Effect of progestin-androgen combinations 
The anti-androgenic effects of some progestins, such as 
cyproterone acetate (CypAc), have been recognized for some 
time. To evaluate the anti-androgenic properties of CypAc in 
mouse kidney, dose response studies were performed using 
θ-glucuronidase activity as an end point. When administered 
alone, CypAc had little effect on β-glucuronidase activity. 
33 
However, when administered in combination with testosterone 
in approximately equal amounts this progestin unexpectedly 
potentiated, rather than inhibited androgen stimulation of 
B-glucuronidase (Mowszowicz et al. 1974). This has been named 
the synandrogenic effects of progestins. 
The mechanism mediating the synandrogenic effects of 
progestins is not completely understood. Several important 
observations must be considered, however. The ratio between 
androgen and progestin was important in determining the type 
of response as the anti-androgenic effect of CypAc was 
manifested as the ratio of progestin to androgen increased. 
The synandrogenic effect was also produced when DHT was used 
as the androgen or when MPA, MegAc or 6MP were used as the 
progestins. 
It was also noticed that the end point monitored was 
important in demonstrating the synandrogenic effects of 
progestins. Androgenic progestins stimulated increases in 
both renal B-glucuronidase and AOH activity and anti-andro-
gereic progestins inhibited the action of both Τ and DHT on 
both erfzymea. By contrast, the synandrogenic effects of 
progestins were manifested only on B-glucuronidase and not 
AOH (Gupta et al. 1978). 
Hydrocortisone was tested with Τ to determine whether the 
synandrogenic effects of progestins were related to their 
glucocorticoid activity. Hydrocortisone had no effect on Τ 
stimulation of β-glucuronidase or ADH activities. Hence, the 
glucocorticoid activity of progestins is not responsible for 
their synandrogenic effects (Gupta et al. 1978). 
3. Mechanism of androgenic effects of progestins 
A. In vitro binding to the androgen receptor 
Sedimentation of mouse kidney cytosol labelled with the 
androgenic progestin, 3H-MPA (Bullock et al. 1978), or 3H-T 
in vitro, revealed Ή-macromolecular complexes sedimenting in 
the 7.9S region of the gradient. The binding of both labelled 
steroids could be eliminated by the addition of 100 fold 
excess of T, P, or several synthetic progestins with andro-
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genie or anti-androgenic activity, MPA, MegAc, CypAc. There 
was no 7.9S binding of either labelled steroid in the cytosol 
from Tfm/Y mice (Bullock and Bardin, 1974). This was taken as 
evidence that the above progestins, capable of simulating or 
modulating androgen action, bound to the androgen receptor. 
The relative affinity of the androgen receptor for Τ and some 
progestins was Т>6МР^>СурАс^МРА β Ρ . The fact that Τ is a 
better competitor than MPA in vitro is consistent with the 
relative inhibitory potencies of progestins on nuclear Ή - Τ 
uptake in vivo studies (Brown et al. 1979). 
В. Nuclear uptake 
Following the i.v. administration of Ή-ΜΡΑ, increasing 
concentrations of radioactivity accumulated in nuclei of 
kidney, submaxillary gland and prostate-seminal vesicles. 
'н-МРА was the only steroid recovered from nuclei (Bullock et 
al. 1978). The low capacity of nuclear uptake of ^H-MPA, 
characteristic of steroid receptor binding, was demonstrated 
by competition experiments with excess MPA (Brown et al. 
1979). The involvement of androgen receptors in mediating 
nuclear retention of MPA was confirmed by the following 
observations: nuclear accumulation could be blocked by the 
addition of androgens; excess MPA decreased nuclear uptake of 
•'H-androgen; and Ή-ΜΡΑ was not retained in nuclei of Tfm/Y 
mice (Bullock et al. 1978). 
In contrast to their relative binding affinities in 
cytosol, the most patent androgenic progestin, MPA, produced 
the greatest inhibition of nuclear Τ binding in vivo followed 
by the androgenic progestin 6MP and the anti-androgenic CypAc 
(Brown et al. 1979). These observations indicate that the 
multiple actions of progestins cannot be accurately predicted 
from their binding affinity to receptors as assayed in 
cytosol (Bullock et al. 1978; Mowszowicz et al. 1974; Gupta 
et al. 1981). 
The data from these in vivo and in vitro studies thus 
confirm the binding of androgenic and anti-androgenic 
progestins to the androgen receptor. It can reasonably be 
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assumed that this binding mediates the androgenic/anti-andro-
genic effects of these steroids in vivo. 
CHAPTER III. Effects of 6a-methylproqesterone (6MP) on mouse 
kidney 
1. Biological effects of 6MP 
6MP is a progestin which was shown to possess androgenic, 
synandrogenic and anti-androgenic effects on mouse kidney 
θ-glucuronidase activity (Gupta et al. 1978). It is the only 
progestin that has been identified with all three effects. It 
stimulated a biphasic increase in RNA polymerase I and II 
activities in normal mouse kidney (Ventura and Bullock, 19Θ3) 
in a manner similar to that reported previously for androgens 
(Janne et al. 1976) and estrogens (Hardin et al. 1976) in 
kidney and other target organs. The unexpected finding that 
6MP also stimulated RNA polymerase activity in kidneys of 
Tfm/Y mice was the first evidence that the effects of 6MP on 
mouse kidney may be mediated in part by another receptor 
besides the androgen receptor. 
6MP also interacted with steroids in an unexpected 
manner. 6MP increased prostate-seminal vesicle weight but was 
much less potent than T. Interestingly, when combined with Τ 
the effect on prostate-seminal vesicle weight was potentiated 
by low doses of 6MP and inhibited by high doses. In contrast, 
low doses of 6MP had no effect on Τ stimulated renal 
θ-glucuronidase activity while the effect of high doses was 
additive in C57BL/6J mice (Brown et al. 1981b). 
2. Mechanism of 6MP action 
A. Nuclear uptake in vivo 
In an effort to determine the mechanism of action mediat­
ing the different effects of 6MP on kidney and prostate-
seminal vesicle a series of studies was done administering 
Ή-6ΜΡ and Зц-Т subcutaneously or intravenously (Brown et 
al. 1981b). When administered subcutaneously, the radio­
activity associated with Зн-6МР relative to Зн-Т, was 10 fold 
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less in plasma and 100 fold less in prostate-seminal vesicle 
nuclei. In contrast, equal amounts of radioactivity were 
recovered from kidney nuclei. When the ^n-hormones were 
administered intravenously to achieve equal plasma levels, 
the radioactivity in prostate-seminal vesicle nuclei 
associated with progestin administration remained less than 
that produced by androgen. However, radioactivity in kidney 
nuclei was 10 fold greater following -Ή-όΗΡ than ^H-T. This 
was further evidence that different factors regulated the 
nuclear uptake and retention of the two steroids in kidney 
and prostate-seminal vesicle. 
To determine the specificity of 6MP nuclear uptake in the 
two organs, nuclear concentration of radioactivity following 
the intravenous administration of ^Н-вМР was compared with 
that of ^н-Т when given alone or following the prior admini­
stration of Τ, 6MP, MPA, CypAc, dexamethasone (Dex), or 
estradiol (E2) (Brown et al. 1981a). When Ή - Τ was used all 
unlabeled steroids inhibited nuclear uptake in both 
prostate-seminal vesicle and renal nuclei. They also had no 
effect or inhibited nuclear radioactivity associated with 
^Н-бМР in prostate-seminal vesicle nuclei. In contrast, renal 
nuclear radioactivity following the ^H-progestin was enhanced 
by the prior administration of all of the unlabeled steroids 
with the exception of E2 which tended to inhibit uptake. 
In support of the physiological effectiveness of 6MP on 
Tfm/Y mouse kidneys, renal concentration of radioactivity 
following the administration of radioactive 6MP, but not Τ or 
MPA, was found. 
During the analysis of nuclear radioactivity it was found 
that a polar metabolite of 6MP constituted the majority of 
the radioactivity in kidney nuclei but only a small fraction 
in prostate-seminal vesicle nuclei (Brown et al. 1981a). A 
nuclear metabolite had not been detected in the studies of 
MPA. Furthermore, the metabolite was also present along with 
6MP in renal nuclei from Tfm/Y mice. This was evidence that 
renal concentration of both 6MP and its metabolite were, at 
least in part, independent of the androgen receptor. 
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In mice pretreated with several radioinert steroids, the 
ratio of the metabolite to 6MP was decreased in kidney 
nuclei. This was due to increased uptake of Ή-6ΜΡ in those 
mice pretreated with MPA, CypAc, and Dex and decreased uptake 
of the metabolite following E2· This may be because steroid 
pretreatment inhibited the metabolism of Ή-6ΜΡ or receptor 
binding and thus nuclear retention of either 6MP or its meta­
bolite was increased or reduced respectively. 
The metabolite was tentatively indentified as the 
20a-hydroxy metabolite of 6MP. This was consistent with 
previous reports of 20a-hydroxy-4-pregnene-3-one being a 
primary metabolite of progesterone (Wiest, 1963). 
The enzyme involved is known to be present in many tissues 
including kidney of other species. The activity of 2Ga-hydr-
oxysteroid dehydrogenase and its role in the 
metabolism and thus the effects of progesterone has been 
described in many tissues primarily for the rat (Weist 1963; 
Howard and Wiest, 1972). It was thus possible that it was 
also important in modulating the effects of 6MP on mouse 
kidney. 
B. In vitro binding of 6MP 
In an effort to better characterize the factors involved 
in 6MP binding and biological activity, kidney minces were 
incubated with ^H-T alone or with various concentrations of 
non-radioactive Τ or the progestins 6MP, MPA, and CPA (Brown 
et al. 1979). Compatible with their binding to the androgen 
receptor, nuclear uptake of Ή-Τ was inhibited by all 
unlabelled steroids, and there was no evidence of potenti­
ation of nuclear uptake. Similar results were obtained when 
two different mouse strains were used. 
6MP, like all other progestins that mimic or modify andro­
gen action, was shown to bind to the androgen receptor. Mouce 
kidney, minced cytosol, was incubated with Ή-Τ and increas­
ing concentrations of the indicated unlabelled steroids. All 
inhibited the binding of ^H-T which binds specificaly to the 
androgen receptor. The following relative binding affinities 
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to the androgen receptor in mouse kidney cytosol were 
established: T^* 6MP>CypAc>MPAâÉP (Brown et al. 1979). 
When the relative affinities of progestins for the andro-
gen receptor determined by the two methods (competitive 
nuclear uptake and relative binding affinity in cytosol) were 
compared, the relative affinities of the progestins for the 
androgen receptor determined in cytosol did not correlate 
with their effects on androgen action. By contrast, the 
relative nuclear uptakes determined in the mince studies cor-
related roughly with the androgenicity of the various 
compounds. Τ is more potent than MPA or 6MP, whereas Ρ and 
CPA have little if any androgenic activity. Other androgen 
modulating effects of progestins do not correlate so well. 
Such apparent discrepancies have also been demonstrated for 
glucocorticoid receptors in hepatoma cells in tissue culture 
(Rousseau, 1984). 
It was thus apparent that 6MP was a very interesting 
compound. It was the only progestin for which androgenic, 
antiandrogenic and synandrogenic effects had been described. 
It was also the only progestin for which an intranuclear 
metabolite had been detected, and for renal nuclear retention 
was dependent in part on a receptor other than an androgen 
receptor (Tfm/Y mice). It was also a compound whose renal 
nuclear uptake was enhanced by other steroids in a manner 
that was not easily determined by in vitro studies. Because a 
better understanding of the mechanism behind these events 
offered the potential of providing a better understanding of 
androgen action it was decided to continue the study of 6MP. 
Characterizing its metabolism and the second receptor were 
thought to be the two most productive studies that could be 
done. 
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Abstract. бо-Methylprogesterone (6MP) is an androgenic progestin that binds to the 
androgen receptor. However, results from an in vivo study suggested that 6MP was also 
bound by a second receptor. In the present study, we found that 6MP was bound in kidney 
cytosoi from adrenalectomized/ovanectomized female mice as well as Tfm/Y mice, which 
lack androgen receptors. 6MP was bound with high affinity (K^ = 1.2 X 10"* M) by a binder 
that was present in 7-8 times greater concentration than the androgen receptor and had the 
specificity of a glucocorticoid receptor. 6MP was bound with similar specificity in liver cyto­
soi. These data indicate that, despite its androgenic effects. 6MP binds primarily to a gluco­
corticoid receptor in mouse kidney. 
Introduction antiandrogenic effects on mouse kidney [1.2] 
with their binding to the androgen receptor 
Although steroids are usually classified ac- [3, 4] and their induction of RNA-poly-
cording to their major physiologic eiTect. they merase activity [5]. The most recently stud-
frequently induce responses characteristic of led progestin. 6o-methylprogesterone (6MP), 
other classes of steroids. These divergent ef- was found to have syn-, anti- and androgenic 
fects correlate with the binding of the steroid eflects in normal female, but not Tfm/Y 
to appropnate receptors. We have investi- mice, which lack effective androgen receptors 
gated a senes of related progestins and corre- (6]. These results were not unlike those we 
lated their androgenic, synandrogenic and obtained with another androgenic progestin. 
medroxyprogesterone acetate (6a-methyl-17-
1
 Supported m pan bv NiH Gram HD 17666 aceto)ty-4-pregnene-3.20-dione. MPA) [1]. 
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However, when the nuclear uptake of 3H-
6MP in kidney and prostate-seminal vesicle 
was characterized, several unexpected results 
were obtained which suggested that 6MP was 
involved with more than just the androgen 
receptor in mouse kidney [6, 7]. In kidney, 
the nuclear retention of radioactivity follow­
ing Ж-бМР administration was relatively 
greater than for ]H-testosterone, while the 
converse was true for prostate-seminal vesi­
cle; the addition of several unlabelled ste­
roids enhanced rather than inhibited the nu­
clear uptake in kidney, but not in the pros­
tate-seminal vesicle complex; and finally, 
similar concentrations of radioactivity were 
retained by renal nuclei in normal female 
mice and in Tfm/Y mice, which lack eflec-
tive androgen receptors [8]. The ability of 
6MP to increase RNA-polymerase activity in 
Tfm/Y mice suggested that this nuclear re­
tention was biologically effective [9]. These 
data were evidence for the specific binding of 
6MP to another steroid receptor in addition 
to the androgen receptor. This paper reports 
on the high afTinity binding of 6MP to a cyto­
plasmic macromolecule in mouse kidney that 
has the characteristics of a glucocorticoid re­
ceptor. 
Materials and Methods 
inimals 
Female CD-I mice (6-β weeks old) were pur-
chued from Charles River Breeding Laboratory. 
Tfm/Y mice and normal controls were obtained from 
a colony maintained by one of the authors (L.B.) All 
mice had access to water and a standard pellet diet 
(Charles River Formula. Country Food/Agway. Syra­
cuse. N Y.). and were housed in a constant 12-hour 
light/dark light schedule with controlled environmen­
tal conditions. Adrenalectomy (Adii and ovanectomy 
(Ov»> were performed under ether anesthesia. 5-7 
days betöre the mice were used lor an expenmem. Adx 
mice were given 0.9% NaCl solution for dnnkmg 
water The mice were killed by cervical dislocation 
between 9 00 and 11.00 h. 
Maienais 
( 1 .Z-'HV-éa-Methyl-progesterone (44 Ci/mmol) 
was specially synthesized at the New England Nuclear 
Corporation (Boston, Mass.). ( 1 .Z-'W-denamelha-
sone (9-Пиго-16a-methyl-11 β, 17a.21 -tnhydroxy-1,4-
prcgnadiene-3.20-dione: 38 Ci/mmol) (Dex) was also 
obtained from New England Nuclear. An aliquot of 
'H-Dex was checked for punty by thin-layer chroma­
tography (chioroform/methanol. 97:3) and JH-6MP 
by a combination of celile column (propylene/ethyl-
glycol. 3:1) and paper chromatography (isooctane/ 
methanol/H;0. 10:10:1). Both 'H-steroids were 
greater than 98 % pure at the tune of use. Testosterone. 
aldosterone, corucosterone. Dex and progesterone 
were purchased from Steialoids. (Wilton. N.H.). 6MP 
was a gift from Upjohn (Kalamazoo. Mich.). Dextran 
T70 was purchased from Sigma (Saint Louis. Mo.): 
charcoal (NontA) from Matheson Coleman SL Bell 
(East Rutherford. N.J.): sucrose-ultra pure (special 
density gradient grade) from Mann Research Labora­
tori« (New York. N Y.). and the scmullator (Uqui-
(luor) from New England Nuclear. All other chemicals 
were of reagent grade. 
Preparation of Tissue Extracts 
The kidneys and liver were freed of fat and extra­
neous tissue, cut into several large pieces and placed in 
ice cold PEMTG-bufier (50 mM PO». 10 m\4 EGT Α. 
ІОп Л/ NaMoO», 10% glycerol, containing 12 mM 
ihioglyccrol which was added fresh daily: pH 7.0 at 
room temperature). Samples were processed as de­
scribed previously [8). Protein concentrations were 9-
12 mg/ml and 20 mg/ml for kidney and liver, respecti­
vely. Protein was determined by the method of Lowrv 
et al. (10) using bovine serum albumin as the standard. 
Binding Studies 
Cyiosol (0.25 ml) was incubated for 3 h with 'H-
steroid without or with excess unlabelled steroids for 
quantitation of total and nonspecific binding, respec­
tively The JH- and unlabelled steroids were added 
separately in 10 μΐ of buffer 'Н-бМР was not metab­
olized during the incubation. Bound and free JH-6MP 
were separated with dextran-coated charcoal ID/C, 
0 5 % ethanol-washed charcoal and 0 05 % dextran in 
PEMTG buffer) D/C (0.5 ml) was added to the mcu-
¿2 
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bated cvtosol (0 I ml), shaken for I min. and centn-
fuged for 2.5 mm at 1.000;. The supeinatant was 
poured directly into counting vials At all levels of 
radioactivity added, the nonspecific binding to D/C 
avenged 4-6% of the total 'H-steroid added. All 
binding studies were done 3 or 4 times and represen­
tative results are shown 
Densuy Sucrose Cemnfugaiion. After incubation 
with 'Н-бМР (18 пМ) or 'H-De» (16 пЛО without or 
with a 100-fold excess of various unlabelled steroids, 
cytosol (0 275 ml) was layered on top of a 5-20% 
sucrose gradient in PEMTG-bufTer and centnfuged in 
a SW 60 rotor for 15 h at 100.000;. Endogenous 
hemoglobin was used as a reference point Gradients 
were fractionated into 0 12-ml fracuons using upward 
dupUcemeni The individual fractions were treated 
with D/C to decrease nonspecific binding, or were 
remcubated with 1H-6MP (9 nM) prior to treatment 
with D/C 
Rtlaiive Binding Studies Kidney cytosol was incu­
bated with 'Н-бМР or 'H-Dei (g nM) alone or with a 
I-. 10· or 100-fold excess of various unlabelled ste­
roids. Bound and free steroids were separated with 
D/C. The results were expressed as a percentage of the 
binding of 'H-óMP or 'H-Dex alone, which was sel at 
100% 
Scatchard Analysis Cytosol was incubated with 
increasing amounts of 'Н-бМР (0 2-45 пЛО or 'H-
Dex ( 1-35 nM). without and with a lOO-fold excess of 
the appropnate unlabelled steroid for determination 
of total and nonspecific binding, respectively Specific 
binding was calculated as the difference between these 
two values Results were obtained by the method of 
Scatchard [ 11 ) as described previously (8) Student s t 
test was used for statistical analysis 
All samples were counted in 5 ml of scintillator 
(42 ml Liquiduor 330 ml Tnton X-100 670 ml tol­
uene) for 10 mm in a Packard Tn-Carb scintillation 
counter(modelNo 3375) The efficiency was32%for 
sucrose gradient fractions counted directly and 34% 
for all the samples treated with D/C 
Results 
Sucrose Gradients 
When 'Н-бМР was incubated wuh kidney 
cytosol from female mice, it was bound by 
macromolecules that sedimented in the 4S 
and 8S regions of the gradient. }H-6MP bind­
ing in the 8S peak was almost completely dis­
placed by Dex and 6 M P. to a lesser extent by 
progesterone and aldosterone, while testos­
terone had little effect (fig. 1). Binding was 
greatly enhanced, especially in the 8S region, 
when individual fractions were 'post-mcu-
bated' with 3H-6MP and treated with D/C 
pnor to counting (fig. 2). The unlabelled ste­
roids competed with the same relative effec­
tiveness as before. Similar results were ob­
tained when kidney cytosol from Tfm/Y 
mice, which lack effective androgen recep­
ton, was analyzed. 
These data suggested that, despite the fact 
that 6MP had androgenic properties in vivo, 
the majority of in vitro 6MP binding m 
mouse kidney cytosol was to a receptor other 
than that for androgens. Because of the 
marked ability of Dex to compete for 'H-
6MP binding, the possibility that 6MP 
bound to a glucocorticoid receptor was inves­
tigated. 3H-Dex was bound bv 8S macromol­
ecules in kidnev cytosol from Adx/Ovx fe­
male mice to a much greater extent than was 
Ή-6ΜΡ (fig. 3) However, the unlabelled ste­
roids maintained the same relative effective­
ness for inhibition as when 3H-6MP was 
used. Similar results were obtained when kid­
ney cytosol from Tfm/Y mice was used. Fi­
nally. similar patterns of competition were 
obtained when }H-6MP binding in liver was 
analyzed. 
Relative Binding 4jjinitv 
The binding of 3H-6MP and 3H-Dex rela­
tive to the unlabelled steroids was more accu­
rately determined bv constructing binding in­
hibition curves In Adx Tfm/Y mice, the 
order of competition for 3H-6MP binding 
was 6MP > Dex > comcosterone > proges­
terone > aldosterone > > testosterone 
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Flg. 1. 6MP binding in 
kidney cwosol. Ή-6ΜΡ 
(18 nM). without and with a 
100-fold excess of unlabeled 
steroids, was incubated with 
cytosol from CD-I female 
mice. The cytosol was centn-
fuged through 5-20% lu­
crose gradients and individ­
ual fractions wet« treated 
with D/C pnor to counting 
Endogenous Hb was used as 
a marker. · = 'Н-бМР: A = 
Ή-6 Μ Ρ and testosterone: 0 
= aldosterone: Δ « progester­
one: • = dexamethasone: о s 
6MP 
(fig. 4). The same order of afTinity was found 
when JH-Dex was used except that Dex was 
slightly a better competitor than was 6MP. 
Similar results were obtained when renal 
cytosol from Adx/Ovx female mice was 
used. 
Scatchard Analysis 
'Н-бМР and Ж-Оех binding in kidney 
cytosol from Adx/Ovx female and Adx 
Tfm/Y mice was analyzed quantitativelv by 
Scatchard analysis (fig. 5. table I). There was 
evidence for binding only to a single sue. For 
each steroid, there was no significant differ­
ence in the Кл determined for female versus 
Tfm/Y mice. In each instance however. Dex 
was bound with about twice the affinity than 
that for 6MP (0.6 ± 0.1 X 10-evs. 1.3 ±0.3 
Χ I0-» \f. ρ < 0.02 in females. 0.7 ± 0.2 X 
10"» vs. 1.2 ± 0.2 X 10-8 Λ/, ρ < 0.5 in 
Tfm/Y mice). The steroids also differed in 
their number of binding sites. For each ste­
roid the female had more binding sites than 
did Tfm/Y mice (p < 0.01). In females both 
steroids were bound by the same number of 
binding sites, while in Tfm Y' mice there 
were fewer sites detected for Dex than for 
6MP. 
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Fig. 2. 6 M P binding in 
kidney cviosol from CD-I 
female la) and Tfm/Y mice 
(Ы Kjdnev cyiosol was incu-
baiedwith 'Н-бМР (18 пЛЛ 
withoul and with a 100-fold 
excess of nonradioactive ste­
roids The cyiosol was cen-
infuged through 5 - 2 0 % su­
crose gradients Individual 
fractions were postincubaied 
with J H - 6 M P (9 ηΛΛ and the 
appropriale unlabelled ste­
roid and then treated »uh 
D/C Endogneous Hb was 
used as a marker Svmbolsas 
in figure I 
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Tibie I. Binding parameten for the steroids in 
mouse kidney cviosol 
Animal 
IO-'.W 
Sites 
fmol/mg protein 
'H-6MP 
Adx/Ovx Temale 3 
Adx Tfm/Y 4 
ІЗіО.Э' 3752 
1.2+0.22 285i 
12.P 
9.54 
'H-Dex 
Adx/Ovx female 3 
Adx Tfm/Y J 
0.6*0.1 
0.7*0.2 
447 +58.9 J 
206*17 9 
Kidney cylosol from adrenaleciomized-ovanecto-
mized (Adx/Ovx) female and Adx Tfm/Y mice was 
incubaicd wiih increasing amounts of 'H-6MP (0.2-
45 n.\f) or 'H-Dex (1-35 ηΛΛ with or wiihoui a 100-
fold excess of the corresponding unlabelled steroid at 
I * С for 3 h Bound steroid was separated from free 
with dextran chaicoal. The results, determined by the 
method of Scatchard. are expressed as means * SE. 
1
 ρ < 0.02: Adx/Ovx female. JH-6MP vereus 'H-
Dex. 
-' ρ < 0 05. Adx Tfm/Y. 'H-6MP venus 'H-Dex. 
1
 ρ < 001. Ή-6ΜΡ or 'H-Dex. Adx/Ovx female 
versus Adx Tfm/Y 
' ρ < 001. Adx Tfm/Y.'H-AMP versus Dex. 
f TT 
i.ioo-
900-
1 700-
с 
ï 500-
> 
I 300-3 
5 
if 100-
; 
- M M * . 
/ЪФ*™ Д 
1 У у/, ConKsiurena/ \ 
/ ÍAV/ ' *"' //~ 
l/ 11 ΛΛ J/ 
r If •''^ \ ^ ' 
/ x ^ ^ y · ^ ' 
ι S io IS M IS 
Prxtion number Toe 
Fig. 3. Dex binding in kidney cytosol from Adx/ 
Ovx female mice. Cviosol was incubated with 'H-Dex 
( 16 пЛЛ with and without 100-fold excess labelled ste­
roids. The binding was fractionated on 5-20% sucrose 
gradients. Individual fractions were treated with D/C 
prior to counting. Endogenous Hb was used as a 
marker. 
Discussion 
Progestins are frequently used clinically. 
both alone and in combination with other 
compounds. This frequent use and the subse­
quent side eflTects that have been reported 
have promoted interest m defining the spec­
trum of the biological edects manifested by 
these steroids. We have shown that a vanetv 
of progestins bind to the androgen receptor 
[3. 4] and may simulate, inhibit or enhance 
androgen action [I. 2. 6. 12]. In our initial 
studies of the etTects of 6MP on mouse kid­
ney, we found that 6MP stimulated andro­
genic responses such as kidney and prostate-
seminal vesicle growth and renal ß-glucuron-
tdase activity [6]. As predicted from these 
androgenic effects. 6MP was apparently 
bound by the androgen receptor as it com-
peted in vitro for 3H-testosterone binding in 
cytoplasm [3. 4]. However, the finding that 
in vivo Ж-бМР was retained in similar 
amounts by kidne> nuclei from normal and 
Tfm/Y mice, which lack androgen receptors. 
was unexpected [7]. This suggested that 
another receptor was also involved. 
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100 -I 
Molar «же«» of nomidiOKtiv« cofnoftilor 
I« 10a 
Molar eicatl of nonradioactiv« competitor 
20 -π 
- ι β -
12 -
3 
3 
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о 
m 
> 4 " 
ä 
* 
1 
m 
ToTil Öinamq ^^*·**^ 
j0r SiWCilic otndinq % 
Л/ ^ ^ ^^ J o i -
/9 ^,,,*»*^ Nonwwcific binding 
t u l i l i l í 
7 5 15 22 5 30 37 5 45 С 
Total iiQtnd concern ra пол nM 
1 1 1 
1 0 2 0 3 0 
Bound nAf 
Fig. 4. Competitive binding оГ various steroids 
with 'Н-бМР la) and 'H-Dex (b) in mouse kidnev 
cvtosol Cuosol Irom Adx ΤΓπνΥ mice was incubated 
with J H - 6 M P or JH-Dex |20 п Ш and increasing con­
centrations oi the indicated unlabelled steroids Bound 
was separated Irom tree steroid with D/C • = Cortico­
sterone Δ = progesterone, з = aldosterone A = testos­
terone о a Dex · = t>MP 
Fig. 5. Binding of 'H-óMP in kidnev cvtosol from 
Adx Tfm/Y mice Cvtosol was incubated with increas-
ing concentrations of 'Н-бМР (0 2—»5 η »Л in ihe 
presence or absence ol a lOO-fold molar excess ot 6 M P 
for 3 h al I "C Bound was separated trom tree steroid 
with D'C Inset Specific binding data plotted accord­
ing to the method of Scatchard. Kd = 1 0 X 10-* \i 
sites = 264 fmol/mg protein 
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Some progestins are known to have gluco­
corticoid or antiglucoconicoid-like effects 
[13-16] and. in some cases, binding to the 
glucocorticoid receptor has been demon­
strated [15, 17-20]. Although the presence of 
a glucocorticoid receptor in rat kidney is well 
recognized [21]. similar data for mouse kid­
ney has only been inferential [22]. The 8S. 
high-affinity, low-capacity renal binding of 
3H-6MP detected in the present study was 
compatible with binding to a steroid receptor 
rather than to a earner protein. Identification 
of this receptor as one for glucocorticoids was 
based on the pattern of in vitro competition 
with cold steroids. Testosterone had little ef­
fect while aldosterone, progesterone, cortico­
sterone. and Dex. steroids known to bind to 
the glucocorticoid receptor, competed for 
binding with increasing effectiveness against 
3H-6MP or 3H-Dex. The number of binding 
sites detected for JH-6MP in normal female 
mouse kidney was 7-8 times greater than 
what we have reported for testosterone [8]. 
The binding of 3H-6MP to an 8S macromole­
cule in liver, a tissue known to have glucocor­
ticoid receptors, that had similar specificity 
as what we had found for kidney gave further 
support to the involvement of a glucocorti­
coid receptor. 
We do not know if the binding of 3H-6MP 
to the renal glucocorticoid receptor is related 
to the enhancement of 3H-6MP nuclear up­
take in vivo by unlabelled steroids, especially 
dexamethasone. which we reported pre­
viously [7]. It correlates, however, wuh the 
absence of this effect in prosiate-seminal ves­
icles which lack glucocorticoid receptors (23). 
Of related interest is our earlier finding that a 
100-fold excess of Cortisol or dexamethasone 
consistently enhanced 3H-iestosierone bind­
ing to the androgen receptor in mouse kidney 
cytosol when analyzed by sucrose gradients 
[8]. Androgen and glucocorticoid receptors 
have been descnbed as allostenc proteins 
with active and inactive forms [24]. It is pos­
sible that the in vivo addition of cenain unla­
belled steroids promotes the formation of 
active forms of the receptor wuh a subse­
quent increase in binding or nuclear reten­
tion. 
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CHAPTER V 
ENDOCRINE RESEARCH, 13(1), 1-14 (1987) 
THE DIFFERENTIAL REGULATION OF THE 
INTRANUCLEAR PROGESTIN IN MOUSE KIDNEY 
AND PROSTATE-SEMINAL VESICLES 
P.W. Houban and L.P. Bullock 
Department of Medicine 
Tufts University School of Veterinary Medicine 
North Grafton, Massachusetts 01536 
ABSTRACT 
This study was designed to confirm the Identity of the enzyme 
Involved In the appearance of a nuclear metabolite of 6a-fflethyl 
progesterone (6MP) 1n mouse kidney but not 1n prostate-seminal 
vesicle. 6MP and progesterone competed for metabolism by the 
kidney enzyme. Using progesterone as substrate, the results of 
recrystallizatlon of the product with 20a-hydroxy progesterone 
supported the Identification of the enzym« as 20a-hydroxystero1d 
dehydrogenase (20aHS0). The enzyme had a substrate specificity 
similar to that reported for 20aHSD in other tissues. Renal 
enzyme activity was higher in female than In male CD-I mice while 
activity was generally lower and without a sax difference In a 
random bred colony. Renal enzyme activity varied slightly with 
the estrous cycle, being highest at proestrus and lowest on day 2 
of diestrus. Little enzyme activity was detected in 
prostate-seminal vesicles. It appears that 20aHSD 1s an important 
factor In regulating the differential presence of the 
20a-metabo11te of 6MP in kidney and prostate-seminal vesicle 
nuclei. 
INTRODUCTION 
Progestins are known to simulata androgen action in a variety 
of tissues (1,2,3). We have shown that this 1s mediated via high 
affinity binding of the progestin to the androgen receptor, 
specific intranuclear retention of the steroid-receptor complex, 
50 
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and nuclear activation (4,5). As part of a study of related 
progestins to determine the steroidal, metabolic, and genetic 
factors involved in the regulation of the androgenic effects of 
progestins, we studied the androgenic progestin, 6a-methyl 
progesterone (6MP). This steroid has androgenic effects on kidney 
and prostate-seminal vesicles in the mouse ( 6 ) . Following the IV 
administration of H-6MP, not only was the parent compound 
recovered from mouse kidney nuclei but also a metabolite which was 
present in even greater concentration ( 7 ) . In contrast, in 
prostate-seminal vesicle nuclei H-6MP was the primary steroid 
retained while only trace amounts of the metabolite were detected. 
The metabolite was tentatively identified as the 20a-hydroxy 
derivative of 6MP (20a-0H-6MP) (6). 
Because this was the first time that we had detected a 
metabolite of an androgenic progestin in kidney nuclei it 
warranted further investigation. This paper reports on studies to 
better identify the putative enzyme involved, 20a-hydroxysteroid 
dehydrogenase (20aHS0), and to determine its role in the 
differential presence of the metabolite in nuclei of kidney but 
not prostate-seminal vesicles, both androgen responsive tissues. 
MATERIALS AND METHODS 
Animals 
Male and female CD-I and C57BL/6J mice, 6-8 weeks old, were 
purchased from Charles River Breeding Laboratory (Wilmington, MA) 
and The Jackson Laboratory (Bar Harbor, ME) respectively. Normal 
5 I 
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male and female mice were also obtained from a closed random bred 
colony maintained by one of the authors (L.P.B). All mice were 
housed at constant temperature (220C) with regulated 12 hour 
light-dark cycles and maintained on a standard mouse diet with 
water available ad libitum. Animals were sacrificed between 9-11 
AM. Estrous cycles were staged by routine vagina! smears and only 
mice with 4 day cycles were used in studies related to the estrous 
cycle and enzyme activity. 
Materials 
(1,2-3H)-6MP (44 d/nmol) was specially synthesized at New 
England Nuclear Corp. (Boston, MA) by selective catalytic 
tr1tiat1on of the Δ -oleflnic bond of 6a-methyl-lt4-pregnad1ene-
14 3 
3,20-dione. (4- O-progesterone (SOmCI/mmol), (1,2- H)-proges-
terone (50 d/mmol), and (l,2-3H)-20a-pregn-4-en-3-one (20aOHP) 
(50 d/imol) were also obtained from New England Nuclear. H-6MP 
was checked for purity by eel i te chromatography (propylene: 
ethylglycol 3:1) and paper chromatography (iso-octane:methanol : 
H.0, 10:10:1); the other steroids by thin layer chromatography 
(chloroform:ethyl acetate, 80:20). The labeled steriods were 
greater than 98% pure at the time of use. 
Testosterone (T), progesterone (P), 20a-hydroxy-4-pregnen-
3-one (20a0HP), 17a-hydroxyprogesterone (17aOHP), 3b-hydroxy-5a-
prtgnan-20-one and 5b-pregnane-3a,20a-diol were purchased from 
Steraloids (Wilton, NH). l7b-estrad1ol, monothloglycerol and 
NA0PH were from Sigma (Saint Louis, MO). Medroxyprogesterone 
acetate (17a-acetoxy-6a-methyl-progesterone; MPA) and 6MP were 
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gifts from the Upjohn Co. (Kalamazoo, MI). Thin layer chromato­
graphy was performed on 20x20 cm glass plates coated with silica 
gel GF-254 (Brinkman, Westbury, NY). All other chemicals were of 
reagent grade. 
Preparation of cytosol fractions 
The kidneys were removed, decapsulated and placed in ice cold 
0.01M potassium phosphate, pH 6.0, and 12 nM monothioglycerol, 
which was added fresh daily (PM buffer). Prostate-seminal 
vesicles were gently expressed and rinsed in 0.9% saline and 
placed in ice cold PM buffer. Tissues were kept cold during 
further processing. Tissues were drained, weighed, minced and 
homogenized (kidneys, 5% wt/vol; prostate-seminal vesicles, 10% 
wt/vol) in PM buffer for 5 sec with a Polytron 10 ST (Brinkman 
Instruments, Westbury, NY) at a rheostat setting of 5. The 
homogenate was centri fuged at 120,000 χ g for 1 hour at 1-40C in a 
Beekman Type 40 fixed angle rotor. Following centri fugati on, the 
top floating lipid layer was removed and the dear supernatant 
(cytosol) taken for assay. 
Enzyme assay 
The enzyme assay was a modification of that described by 
Weist (8). The incubation mixture was pre-warmed in a water bath 
to 370C for 5 min after which the reaction was initiated by the 
addition of 0.2 ml cytosol containing 0.4-0.5 mg and 0.31-0.37 mg 
protein for kidney and prostate-seminal vesicle, respectively. 
The final reaction mixture contained ( H)-6MP (1.1 pmoles), 200 
nmoles of the indicated steriod, NA0PH (1 umole) and 10% ethanol 
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1n 3.0 ml PM buffer. The Incubation was continued with constant 
shaking (70 cycles/mi η) for 30 min. Duplicate 10 ul allquots were 
removed to determine total cpm/assay prior to termination of the 
Incubation by the addition of 7 ml of petroleum ether. Under 
these conditions metabolite formation was linear with respect to 
time and protein concentration. 
Twenty ug of 6MP and 20aOHP were added to the reaction 
mixture for use as markers. The reaction tubes were shaken by 
hand for 1 min and the aqueous phase removed. The petroleum ether 
phase was washed successively with 3 ml of 0.1 N NaOH, 6% acetic 
add and distilled water. A volume between 6.0 and 6.5 ml was 
dried in a 370C water bath under a gentle stream of air. 
Dried samples were applied to thin layer plates which had 
been pre-run 1n acetone. Chromatograms were developed in 
chloroform:ethyl acetate (80:20). (3H)-6MP was located by UV 
visualization of authentic 6MP. Since 20a-OH-6MP ran slightly 
faster than 20a-OHP, (3H)-20a-0H-6MP was considered to be in the 
area of the UV visible spot of 20aOHP and 1/2 cm above it. Dried 
eluates from these spots as well as the areas in between were 
counted in 5 ml toluene-Llqulfluor (New England Nuclear, Boston, 
MA) (111:42) for 20 min at an efficiency of 35%. The cpms in each 
fraction were added to determine recovery [62 + 4% (SO)]. The 
data, corrected for loss, are presented as percent conversion to 
( H)-20a-0H-6MP recovered in the presence of various substrates or 
as nmol/mg protein/30 min. 
To confirm the presence of 20aHSD activity in mouse kidney, 
14 
enzyme assays were performed as described above using ( C)-P as 
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substrate and recrystallization of the product with ( H)-20aOHP 
(10,000 cpm) and 20 mg of the samt steroid. The steroids were 
co-crystallized 3 times from heptane:ethyl acetate (1:1). 
Protein concentrations were determined according to Lowry (9) 
using bovine serum albumin as standard. Statistical calculations 
were done using Student's t-Test. 
RESULTS 
We chose to confirm the presence of an enzyme with 20aHS0 
activity by co-crystallization of the labelled metabolite with a 
known standard. Because appropriate labelled and uni abel led forms 
14 
of 20a-0H-6MP were not commercially available, we used ( C)-
progesterone as substrate and co-crystallized the product with 
(3H)-20a0HP of low specific gravity. The constant 1 4 C / H ratios 
in the crystals and mother liquor confirm the metabolite as the 
20a-hydroxy derivative of progesterone (Table I). 
Several studies were then done to partially characterize the 
substrate specificity of the enzyme involved in the metabolism of 
6MP. To demonstrate that Ρ and 6MP were competitors for 
metabolism by renal 20aHS0, ( H)-6HP was incubated with and 
without excess Ρ (200 nmoies) and vice versa. The addition of the 
unlabeled steroid reduced the formation of the labeled product 
from (3H)-6MP and (3H)-P by 93% and 89% respectively. (3H)-6MP 
was also incubated with excess 3b-hydroxy-5a-pregnan-20-one, 
17aOHP, 5b-pregnane-3a,20a-d1ol, MPA, estradiol, and testosterone. 
The first compound resulted in a significant reduction (60%, 
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TABLE I 
Crystallization of ( C)-20a-hydroxy progesterone formed from 
( C)-progesterone by kidney cytosol. 
Crystallization 
Start 
1 
2 
3 
Crystals 
0.56 
0.56 
0.56 
14C/3H 
Mother Liquor 
0.51 
0.39 
0.57 
0.56 
Kidney cytosol was incubated with ( C)-progesterone and the 
product isolated by thin layer chromatography as described. 
Following elution, ( H)-20a-hydroxy-progesterone (10,000 cpm) and 
20 mg unlabelled steroid were added and the mixture crystallized 3 
times from heptane:ethyl acetate (1:1). 
p<0.01, n=6) and 17a0HP was associated with a slight reduction in 
the formation of the labelled metabolite. The other compounds 
were ineffective. These results are similar to what has been 
reported for 20aHSD in the ovary (10). 
In the competition studies above, product formation was 
somewhat higher than we had expected from earlier studies. We 
realized that these studies utilized CD-I males while many of the 
earlier studies had used C57BL/6J mice. This suggested that there 
might be a strain difference in renal enzyme activity. This was 
supported by the finding that not only did CD-I mice have 
generally higher enzyme activity than mice in our own colony but 
that female CD-I mice had higher activity than males (108 + 20 vs 
5 3 + 5 nmoles/mg/30 min) (Mean • SE, n=30,10), while there was 
little sex difference in enzyme activity in mice from our colony 
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(27 + 3 vs 24 i 2 nmoles/mg prote1n/30 min) (n=18,6). In 
preliminary studies of C578L/6J mice, a sex difference was also 
found and the overall enzyme activity tended to be intermediate 
between CD-I and our mica. 
In rats, ovarian 20aHS0 activity has been shown to vary with 
the day of the estrous cycle. We determined murine renal enzyme 
activity during the estrous cycle to see if similar changes could 
be detected. The only significant difference that was detected 
was the lower activity on day 2 of diestrus as compared to 
proestrus, the day of highest activity (p=0.02) (Table II). 
Enzyme activity in prostate-seminal vesicle was measured in 
CD-I males in the presence of both (3H)-6MP and (3H)-P. Enzyme 
activity was not significantly above background for either 
substrate. 
DISCUSSION 
In early studies, the metabolism of testosterone to its 
5a-reduced metabolite, 5a-dihydrotestosterone (DHT), was thought 
to be a prerequisite for androgen action since DHT was the 
intranuclear androgen in the prostate atid other classical androgen 
target organs (11,12). However, we, as well as others, found that 
in some tissues, including mouse kidney, testosterone was not 
metabolized but was itself bound by the androgen receptor, 
concentrated in the nucleus and thus acted directly (12-15). If, 
however, DHT was administered to the mouse, it was bound and was 
the active, intranuclear renal androgen (13). It became apparent 
that the androgen receptor has high affinity for both testosterone 
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TABLE II 
Mouse renal 20a-hydroxysteroid dehydrogenase activity during the 
estrous cycle. 
Day of Cycle η Enzyme Activity 
Proestrus 9 
Estrus 8 
Diestrus-1 6 
Diestrus-2 7 
The day of cycle was determined by vaginal smears in CD-I mice. 
( H)-6a-fflethy1 progesterone was used as substrate and the 
formation of the 20a-hydroxy metabolite by renal-cytosol 
determined (nmoles/mg protein/30 min). 
*p=0.02 as compared to proestrus 
and DHT and that the intranuclear androgen is determined by the 
presence or absence of Sa-reductase activity. As expected, this 
enzyme activity was not present in mouse kidney (16). The 
intranuclear concentration of steroids in target tissues is thus 
regulated by both receptor affinity and enzyme activity. 
We have also shown that progestins exert their androgenic 
action on mouse kidney via the androgen receptor (4). As with 
testosterone, the androgenic progestin, MPA, was concentrated, 
unmetabolized by target nuclei and thus acted directly. However, 
the finding of 6MP as well as significant concentrations of a 
metabolite In kidney nuclei (7) suggested that, for at least some 
progestins, metabolism could be an important regulatory factor in 
this tissue. The simultaneous absence of negligible 
concentrations of the metabolite 1n prostate-seminal vesicle 
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nuclei prompted several questions concerning the factors 
regulating the active nuclear species of this progestin in the two 
tissues. 
The present study was designed to characterize the enzyme 
Involved in 6MP metabolism and its role in determining the nuclear 
species. The confirmation, by product identification and 
substrate specificity, that an enzyme with 20aHSD activity was 
responsible for the metabolism of 6MP in kidney was not surprising 
in view of the variety of tissues (17-23), including rat (24) and 
rabbit kidney (25), in which similar activity has been reported. 
The virtual absence of enzyme activity in prostate-seminal 
vesicles provided one explanation for the absence of the metabo-
lite in nuclei from this tissue. 
In an earlier study we characterized the binding of 6MP in 
mouse kidney and found that BMP was bound not only by the androgen 
receptor but also by the glucocorticoid receptor (26). If the 
metabolite was also bound by the glucocorticoid receptor, as 
suggested by its presence in renal nuclei of Tfm/Y mice lacking 
effective androgen receptors, the absence of a glucocorticoid 
receptor in prostate-seminal vesicle (27) provides a second 
explanation for the differential nuclear concentration of the 
metabolite in the two tissues. We have no proof that mouse kidney 
has progesterone receptors so their role was not considered. The 
final evaluation of the importance of the glucocorticoid receptor 
in determining the intranuclear progestin in these two tissues 
awaits synthesis of the metabolite for definitive binding studies. 
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Nevertheless, these results demonstrate the importance of 
enzyme-receptor interactions In determining the biologically 
active steroid. 
It was not particularly surprising to find evidence for 
sexual dimorphism In the activity of ZOaHSD In CD-I mice since 
sexual dimorphism has been reported for a variety of other murine 
renal enzyme activities (28). However, the higher activity 1n 
females as opposed to males, and the absence of sexual dimorphism 
In mice from our own colony was unexpected since In most previous 
examples of sexual dimorphism in mouse kidney the activity in 
males was higher than 1n females and was seen In all strains 
studied (28,29). In addition, renal 20aHSO activity in rats has 
been reported to be higher in males than in females (24). 
Androgens have been proposed, however, as inhibitors of 20aHSD 
activity in the mouse adrenal (30) and they may have similar 
effects in the kidney. It could also be that renal 20aHSD in 
mouse kidney is regulated In the same manner as some hepatic 
endpoints in the rat in which sexual dimorphism has been 
demonstrated, but the direction and magnitude of male-female 
differences vary between strains (31). 
In rats, ovarian ZOaHSO activity Is highest during proestrus 
and estrus and lowest during diestrus (32). This is due primarily 
to changes In enzyme activity in the regressing corpora lutea 
(33). Somewhat surprisingly, we found that not only was renal 
activity higher during proestrus than day 2 of diestrus but that 
the relative changes were also similar to those reported for the 
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ovary. The similarity of the factors regulating enzyme activity 
in these two tissues remain to be determined. 
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Summary 
Renal ornithine decarboxylase (ODC) activity was evaluated in normal female, male, testosterone-treated 
female and androgen-insensitive Tfm/Y mice for its heat sensitivity and in vivo half-life. ODC activity in 
normal female kidney consisted of 2 forms which differed in their heat sensitivity at 46° C. Androgens. 
either endogenous in normal males or administered exogenously to females, induced pnmanly the 
heat-sensitive form. Results from mixing expenments indicated thai the heat-sensitive form represented a 
change in the property of the ODC activity rather ihan a change in cytoplasmic factors. The in vivo 
half-life of ODC activity was increased slightly in males and short-term androgen-treated females over 
normal females and was markedly increased by prolonged androgen treatment, (n vivo, the androgen-tn-
duced. heat-sensitive form decayed faster than did the heat-resistant form. We conclude that androgens 
have specific effects on both the amount as well as the biochemical properties of ODC activity in mouse 
kidney. 
Ornithine decarboxylase (ODC. EC 4.1 1.17) is 
the first and rate-limiting enzyme in the biosynthe­
sis of polyanunes. These latter compounds are 
found ubiquitously in living organisms and have 
been linked to cell growth. ODC jcuvity is in­
duced in a vanety of tissues by numerous stimuli 
such as drugs, hormones, growth factors, toxins 
and carcinogens (Canellalus et al.. 1979: Moms 
and Fillmgame. 1974; Tabor and Tabor. 1976). 
The increase in activity is rapid and may reach 
levels many-fold above baseline values. 
In the mouse kidney, androgens stimulate 
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growth as well as ал increase in the activity of a 
vanety of different enzymes (reviewed in Bardin et 
al.. 1978; Swank et al.. 1978). We have been using 
ODC activity as an endpomt to study the andro­
genic response of this organ. We found that, de­
spite the numerous known inducers of ODC acuv-
ity. androgen induction of this enzyme in mouse 
kidney was highly specific and dependent on func­
tional androgen receptors (Bullock. 1983). An in­
crease in ODC activity could be detected within 
hours of androgen administration. The activity 
rose rapidly and reached a maximum of several 
hundred limes basal levels after 3-5 days of treat­
ment. This combination of a rapid and large re­
sponse had not been found in the previously 
studied endpomts of androgen action on mouse 
kidney. It thus seemed that, although ODC may 
represent only a few tenths of a percent of the 
total soluble protein (Pegg et al.. 1984). it could be 
0W3-T207/M/IO3 0O J 1984 Elsevier Scientific Publishers Ireland. Lid. 
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a useful tool for studying gene regulation and was 
worthy of further study This paper reports on our 
subsequent findings that basal renal О DC activity 
consists of two forms that can be distinguished by 
heat denaturation and in vivo half-life charactens-
tics. Androgen treaunent induces рпталіу the 
heat-sensitive form. 
MaMriab and methods 
Maunali 
EDTA. pyndoxal-S'-phosphate. L-omithine hy-
drochlonde. cycloheximide and hyamine were 
purchased from Sigma Chemical Co. (St. Louis. 
MO), dithiothrettol (DTT) from Calbiochem (La 
Jolla. CA). Tns from Schwartz-Mann Chemical 
Co. (Orangeburg. NY). L-{l-14C]Oniithine (45 
mCi/mmole) and Liquifluor were from New Eng­
land Nuclear, and [4,5-'Hlleucmc (34 Сі/ішпЫе) 
from Amersham-Searle (Arlington Heights. IL). 
Testosterone pellets (30 mg) were a gift from Dr. 
Kenneth Paigen. University of California at Berke­
ley. and difluoromethyl ornithine (DEMO) was a 
gift from Merrell International (Strasbourg. 
France). The remaining chemicals were of reagent 
grade quality. 
Animais 
C57BL/6J mice were obtained from the Jack­
son Laboratory (Bar Harbor. ME) and Tfm/Y 
mice from the colony maintained by one of the 
authors ( L.P В ). All mice had access to a standard 
pellet diet (Charles River Formula. Country 
Foods/Agway. Syracuse. NY) and water ad libi­
tum. The mice were housed in a constant 12 h 
light/dark environmentallv controlled room and 
were 8-12 weeks of age when killed. 
Ноніюле therapy 
In studies of the response to androgens, mice 
treated for 16 h were given a single s.c. injection of 
1 0 mg of testosterone enanthate and those treated 
for several davs were given a single testosterone 
pellet implanted s.c. under light ether anesthesia. 
Mice were killed between 9 and 12 a.m. 
Préparation of tissue extracts 
Animals were killed bv cervical dislocation. 
Kidnevs were excised, dissected free of fat and 
extraneous tissue, and homogenized if to be used 
for immediate assay, or frozen whole on dry ice 
and stored at - 70 ° С for no more than 24 h. This 
storage did not affect enzyme activity. In prepara­
tion for assay, all tissues were minced and homog­
enized at a rheostat setting of 5.5 with a Potytron 
homogemzer (Bnnkman Instruments. Westbury. 
NY) for 5 sec in 1.5-4.0 ml of ice-cold homogem-
zation buffer (25 mM Tns-HCl. pH 7.4 at 22'С. 
0.1 mM EDTA. 2.5 mM DTT). The tissue homog-
enate was centnfuged at 15000 x g for 30 nun at 
4° С The supernatant was removed with a Pasteur 
pipei and was used to determine ODC activity. 
Determination of ornithine decarboxviase (ODC) ac-
twm 
The supernatant was diluted appropriately with 
homogemzation buffer and ODC activity was 
determined by the method of Pegg and McCill 
(1979) which quantitates the release of ' 4 C 0
:
 from 
[l-'4C]ormthine. The reaction was stopped with 5 
N H,S0 4 . Samples were counted in 10 ml of 
toluene-based scintillation fluid in a Packard Tn-
Carb scintillation counter (Model No. 3375) with 
an efficiency of 521. Protein concentration was 
determined by the method of Lowry et al. (1951) 
using BSA as standard. Activity is expressed as 
percentage of control except where noted. One 
unit of activity - 1 nmole CO, formed/30 min/mg 
protein. 
Biochemical studies 
To determine the heat denaturation profile of 
renal ODC activuv. the supernatant was prein-
cubated for 0-80 mm at 46 0 С. The samples were 
then transferred to an ice bath, diluted if neces­
sary. and assaved for ODC acuvity In some stud­
ies samples from normal and testosterone-treated 
female mice were mixed pnor to heat denatura­
tion. To determine the endogenous half-life of 
ODC activity, mice were given 50 mg cyclohexi-
mide/kg body weight in 0 5 ml saline t ρ and 
killed S mm to 4 h later. When lotal protein 
synthesis was determined. [JH]leucine (50 μΟ) 
was administered i.p. IS mm before the animals 
were killed. Incorporation of labeled amino acids 
was determined by tnchloroaceuc acid precipita-
non of toal protein onto filter paper (Watson and 
Paigen. 1978) 
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Results 
The heat denaturalion of ODC activity in kid­
ney cytosol from normal female, testosterone-
treated female and androgcn-inscnsiuve Tfm/Y 
nuce is shown in Fig. 1 In untreated female and 
Tfm/Y mice (starting actiniy 0.33 and 0.27 units 
respectively) a biphasic curve was obtained, sug­
gesting the presence of heat-sensiuve and resistant 
forms of ODC activity m approximatelv a 3 7 
ratio. In contrast, after females had been treated 
with testosterone for 6 davs. most of the activity 
was of the heat-sensitive form (starting activity 
103 units). The heat denaturalion curve for cytosol 
from untreated males was similar to that of 
androgen-treated females. Enzyme activity could 
be eliminated by the inclusion of DFMO (40 mM). 
100 
50 
20 
10 
5 
2 
NS. 
• S O — Tfm/Y 
\ ",,^··. . ? 
ч \ 
\ 
Testosterone \ 
\ 
\ 0 
о 
υ 
»a 
>-
> 
υ 
< 
υ 
α 
о 
20 4 0 60 80 
TIME (Mm) 
Fig. 1 Heal sciuiiiviiv of moute renal ornithine deurboavlaae 
Ю О О aciivitv Cvtotols from normal Temala ι · ι androgen-
miciuilive Tfm/Y (•! or female mice that had been ircaled 
with icMoucroiie for Ь dávt ι О > were incubale«! al ¿6 β С Jot 
ihe и н к shown i f u r which O D C acuviiv was ileiermined The 
•uliviiv fiK each ^viosol was used as Ihe individual conirol 
value. Sec leal for siafling ещ т · acliviiiea. 
a specific inhibitor of ODC activity, to the incuba­
tion flask. 
Kjdney cytosols from nonnal and 2-day 
androgen-treated female mice were ir'ied to de­
termine if the androgen-mduced change in heat 
sensitivity was due to modification in the character 
of ODC itself or due to induction of unknown 
cytoplasmic factors (Fig. 2). In this experiment. 
ODC activity in cytosol from the normal females 
decreased to 38% of its original value while only 
2.0% of the original activity remained in cyiosol 
from the androgen-treated mice after 80 nun of 
incubation at 46° С As before, biphasic and um-
phasic denaturalion patterns were apparenL Since 
starting activity in cytosol from the androgen-
treated mice was 70 times that of the untreated 
mice (16.7 vs. 0.23 units), the cytosols were mixed 
in respective ratios of 1 70 or 1 35 to give equal 
contributions of enzyme activity but unequal pro­
portions of cytosol. The resulting denaturalion 
curves had characteristics that were intermediate 
between the two progenitor curves (Fig. 2). The 
pattern was consistent with the mixing of two 
4 0 
T I M E ( M k i ) 
Fig. 2 Heal sensitiviiy of mouse renal ornithine decarhoxvlase 
(ODC) activity CvtosoJs from nonnal females ( · | femaJes 
treated with icMotunm* for 2 davs I · ) or nuaed in rauos of 
~0 I and ii 1 normal to treated cvtosoL were incubated at 
4 4 β С for ih« tima shown alter which ODC activity wa^ 
dciaiiiunad See leal for stanmg enzyme acliviuea. 
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units) in normal females appeared to be made up 
of two types with half-lives of 9 and 90 mm. In the 
presence of androgens, however, pnmanly one 
form of ODC activity was present with a half-life 
that increased with increasing duration of andro­
gen treatment. The half-lives in females treated 
with a high dose of androgen for 16 h (data not 
shown) and normal males (starting activity 10.1 
and 4.5 units respectively) were similar and only 
slightly longer than that in normal females. ODC 
half-life increased markedly, however, to 73 and 
120 mm in females treated for S and 32 days 
respectively (starting activity - 111 and 142 units). 
In subsequent expenments designed to confirm 
the apparent biphasic nature of the ODC half-life 
in normal females, we found that ODC activity 
began to increase after reaching a nadir about 60 
mm following the administration of cycloheu-
mide. This could not be ascribed to a 'blank' 
problem since protein concentration and the 
amount of [uC]ornithine added were held con­
stant throughout the experiment and were such 
that adequate enzyme activity could be measured 
at all times. The addition of inhibiting amounts of 
DFMO (40 mM) directly to the cytosol to be 
assayed reduced enzyme activity even further. 
Surprisingly, despite the administration of a rela­
tively high dose of cycloheximide (30 mg/kg i.p.), 
we found that protein synthesis did not appear to 
be inhibited for the duration of the expenment 
(Table I). ['HILeucine incorporation into total 
protein appeared to increase in both liver and 
kidney 30-60 mm after the administration of 
cycloheximide. We found that in kidney this ap­
parent return of protein synthesis occurred regard-
TABLE I 
ORNITHINE DECARBOXYLASE (ODCI ACTIVITY AND TOTAL PROTEIN SYNTHESIS AFTER CYCLOHEXIMIDE 
TREATMENT 
O D C acuvm 
TouJ protein 
svnthais 
Tiuuc 
K.doey 
Kidney 
Liver 
Time 1 mini 
0 
2 1 0 ' 
5320" 
I W O 
30 
45 
350 
sao 
60 
:
_
8 
40 
ω 
1505 
«20 
C57BL/6J female mice ware fivoi >0 mg/kg cvcloheiimide ι p. at time 0 and 50 цСі [ 'Hlleucinc 13 mm pnor to ucnfice. 
* ODC κΐινην nmotes ' 4 C 0
:
 reteucd/30 nun/mg protein 
" Total protein svnthens cpm/mg protetn 
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I 1 
Ό 80 160 240 
TIME (Мш) 
Fig. 3. HtlMiíe Ы mouse гшші onulhinc decaíЬожуіаае activ­
ity Мке were liven SO mg/k| cydoheunude t p. at time 0 and 
killed at the umea shown Normal female (O). normal male 
(· ) . femalea treated for S (A) and 32 days «•! with tesloaterone. 
types of enzyme activity in roughly equal amounts 
rather than a mixing of cytoplasmic factors in 
markedly unequal ratios. 
To determine if the two forms of ODC activity 
that differed in heat sensitivity in vitro could be 
related to physiological changes in vivo, we 
examined the in vivo half-life of ODC activity 
following cycloheximide administration to normal 
male and female mice and female mice undergoing 
androgen treatment (Fig. 3). ODC activity (0.3 
20 40 60 80 
TIME (Min) 
100 
so 
20 
10 
s 
г 
ν* 
ν 
ν 
Ό 20 «Ο 60 30 
TIME {Μιη| 
100 
50 
20 
IO 
5 
2 
ч 
\ 
\ 
\ ( ^ 
40 90 120 
TIME (Mm) 
Fig. 4 Heal tetuuviiy of moiue mul omilbiiw decartoonylu« activity Tollowiiig cydohcuimide ireatmanL Nomul female i leftk. mak 
Icenicr)and female mice treated with lesltMleronefor 3 davsmghii were given 30 mg^kgcvcloneainudei ρ at mnaOand killed al the 
lime ifwwn within the bodv of the figure Renal cytosoU were then incubaied at 4* β С for the limes ihown on the abKisaa prior ю 
being auaved for ODC atuvitv 
las of whether repeated doses of cycloheximide 
were given everv 30 min or whether (he animal 
was normal or androgen-trcated Blank values. 
determined by adding ('Hjleucine directlv to ho-
mogenates. were 10-151 of what was incorpo­
rated at the nadir of protein svnlhesis. It thus 
appears that the mouse may be relanvelv resistant 
to inhibition of protein synthesis by cyclohexi­
mide We cannot explain, however whv. despite 
the evidence that cvcloheximide may not have 
been effective bevond an hour, the ODC acuvitv 
in androgen-lreated animals did continue to de­
crease linearlv for up to 240 mm ( Fig. 3) 
To determine if we could detect changes in the 
in vivo degradation rates of the two forms of ODC 
activity differentiated bv the heat denaluration 
studies, we examined the heat denaluration char-
actenstics of ODC activity at various times after 
cvcloheximide administration (Fig 4) In normal 
female mice, heat-sensitive and insensitive forms 
of ODC activitv were evident pnor to cvclohexi­
mide treatment (starting activitv - 0 42 units) 
However, after cycloheximide there was a continu­
ous loss of the heat-sensitive form In normal 
males (surfing activity — 3 7 units) there was rela­
tively more of the heat-sensitive form of ODC 
activity present minali ν but. following cyclohexi­
mide. this form appeared to decay at a faster rate 
so that there was a relative increase in the con­
centration of the heat-resistant form with time. In 
females treated for S days with androgen (suning 
activity - 195 units) only a heat-sensitive forni of 
ODC activity was detected, regardless of whether 
the activitv was charactenzed 30, 60. 120 (data not 
shown) or 240 nun after cycloheximide treatment 
The androgen responsiveness of ODC acuvitv 
in mouse kidney has been known for at least a 
decade (Crahn et al.. 1973). but it has only re­
cently received much aitenuon. The magnitude 
and rapidi tv of response, as well as the potential 
for differences in the regulation of the response 
among inbred strains of mice, make ODC a valua­
ble probe for the studv of gene regulation (Bul­
lock. 1983. Pajunen et al.. 1982. Seelv et al. 19821 
The presence of 2 forms of mouse kidney ODC 
that differ in their in vitro heat sensitivity and 
androgen inducibilitv enhances this marker s use­
fulness The elimination of enzvme activity bv 
DFMO. a specific irreversible inhibitor of ODC 
activitv. reduces the probability that 2 different 
decarboxylases were being assayed The results of 
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the mixing expenmenc in which samples were 
muted to provide approunutely equal amounts of 
enzyme activity but greatly different amounts of 
cytotol protein, suggested that the induction of a 
heat-sensitive form was not due to changes in 
other cytoplasmic elements but due to changes in 
the character of the ODC activity itself. The 46" С 
tempel ature used in the denaturauon studies ap­
peared to be critical since we did not see the 
biphasic response when samples were incubated at 
SI^CorST-C. 
ODC activity is generally known for its ex­
tremely shon half-life (Russell and Snyder. 1969) 
It ι· known, however, that in several tissues this 
parameter mav increase in association with an 
increase in enzyme activity (McCann, 1980) Seely 
et tl (1982) first reported that the phenomenon 
occun with the large increase in renal ODC activ­
ity that is stimulated by exogenous androgen Our 
results confirm and extend their data to show that 
increases in ODC acuvitv and in vivo half-life are 
not directly linked When compared to normal 
females, the modest increase in enzyme activity 
induced by the endogenous androgens of males 
was associated with a slight increase in half-life 
However, when female mice were treated with a 
large dose of testosterone for onlv 16 h. although 
ODC activity was twice that of males, the in vivo 
half-lives were similar When androgen treatment 
continued for S davs. both ODC activity and 
half-life increased markedly However, although 
continued androgen treatment had little effect on 
ODC activity, its half-life increased even further 
These results suggest that the increase in ODC 
acuvitv is pnmanlv related to the degree of ODC 
induction and to a lesser extent to the duration of 
stimulation, while the converse is true for ODC 
half-life 
How androgens alter the degradation of ODC 
activity has not been elucidated but is associated 
with a change in the rate of loss of ODC molecules 
(Isomaa et al. 1983 Seelv and Pegg. 19831 rather 
ι han bv inactivación bv an inhibitor although an 
inhibitor antizvme. has been reported to be pres-
ent in several tissues of the rat (McCann. 1980) it 
has not been found in rat or mouse kidney (Mc-
Cann. 1980 Seelv and Pegg. 1983) Despite us 
magnitude, the increase in half-life is not sufficient 
to account for the dramatic increase in ODC acuv-
itv that occurs with androgen stimulation Instead. 
this is pnmanlv related to an increase in ODC 
mRNA and subsequent enzvme svnthesis ( Kontula 
et a!.. 1984. Pegg et al. 1984) 
We cannot explain our apparent inability to 
stop protein synthesis with cycloheximide for 
longer than 1 h The fact that protein synthesis 
resumed in the liver as well as the kidney eliminated 
the possibihtv that, following the ι ρ injection. 
much of the cycloheximide was removed by the 
liver and an ineffective dose reached the general 
circulauon and the kidney However, despite these 
data on protein synthesis. ODC activity continued 
to decay exponentially for over an hour in andro-
gen-treated mice It is possible that ODC synthesis 
did resume in these mice but was not detected 
against the high background that still remained 
following androgen induction 
How the different forms of ODC activity are 
related and regulated within and between tissues is 
not yet undentood Two forms of ODC activity 
have been reported for £ coli (Moms and Pardee. 
1965). slime mold Phvsarum -poivcephalum 
(Mitchell. 1981) 3T3 fibroblasts (Clark and Fuller 
1976) and rat and calf liver (Haddox and Russell. 
1981 Obenrader and Proutv 1977 Pereira et a!.. 
1983. Richards et al. 1981) A vanety of mecha­
nisms were used to distinguish the two forms. 
including affinities for ornithine or the cofactor. 
5'-pyndoxvl phosphate, heat sensitivity, and dif­
ferences in size and charge The mammalian 
enzymes differed in charge but not size (Haddox 
and Russell. 1981 Obenrader and Prouty. 1977. 
Pereira et al.. 1983, Richards et al. 1981). and in 
rat liver bv differences in heat sensitmtv (Oben­
rader and Prouty, 1977) and half-life (Pereira et 
al. 1983) Although there are examples of changes 
from one form to another in association with 
induction of overall enzvme activity in the mam­
malian systems (Clark and Fuller. 1976 Oben­
rader and Proutv. 1977) onlv in Phvsarum were 
the changes sufficient to account for the change in 
acuvitv (Mitchell. 1981) Post-translational modifi­
cation of ODC acuvitv bv phosphorvlation (Atmar 
and Kuehn 1981) and iransglutamination (Rus­
sell. 1981) has been reported to occur However in 
these cases the modifications were associated with 
a reduction in enzvme acuvitv Whether the two 
forms of ODC acuvitv in mouse kidney are related 
6 9 
io différent genes or posi-translational modifica-
tion is not known Pegg et al (1984) reponed no 
evidence of multiple forms of mouse kidnev ODC 
using a monoclonal antibody However the 
mateiui used for antibody induction was from 
androgen-induced mice in which one form pre-
dominates 
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CHAPTER VII 
Differences in the Androgen Response 
Between Two Mouse Species 
Paul W. Houben,'2 Leslie P. Bullock,'3 and Thomas O. Fox4 
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Renal weight and ß-glucuronidase activity are two of several well-character-
ized androgen-responsive parameters in Mus musculus. A similar sexual 
dimorphism was not reported for a second mouse species. Mus caroli, 
however. Since this was not associated with a general absence of androgen 
action, we considered whether a localized defect in androgen receptors or a 
difference in renal androgen-responsive endpoints in the two species existed. 
Only minor differences in the characteristics of renal androgen receptors 
from the two species were found when they were analyzed by two different 
methods. These differences were not thought to be sufficient to account for 
the apparent renal androgen unresponsiveness. No differences were found in 
androgen receptors from brain. Subsequently, a third renal endpoint. orni-
thine decarboxylase activity, was found to respond to androgen stimulation 
in Mus caroli. Control of renal androgen action in these two mouse species 
thus differs at the level of genetic regulatory elements. 
KEY WORDS: Mus musculus: Mus caroli; kidney; androgen. 
INTRODUCTION 
The androgen responsiveness of the kidney in the standard laboratory mouse, 
Mus musculus, has been well characterized (Finlayson et al., 1968; Kocha-
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Ician et al., 1948; Ohno et al., 1970; Schwarzlose and Heim, 1973; Swank et 
al., 1978). The effects of endogenous androgens are manifested by a sexual 
dimorphism in renal size and in the activity of several renal enzymes. 
Exogenous androgens induce cellular hypertrophy in the proximal convoluted 
tubule as well as an increase in specific enzyme activities in both male and 
female mice. These androgenic responses are dependent upon the presence of 
functional androgen receptors (Bardin et ai, 1973). In a survey of several 
species of wild mice, Mus caroli were found to lack sexual dimorphism in 
kidney size and in the activity of /Э-glucuronidase (Swank et al., 1978), a 
well-characterized androgen-responsive renal enzyme in M. musculus (Ko-
chakian et al., 1948; Swank et ai, 1978). There was no evidence that this was 
due to a general absence of androgen action, as the males were fertile and 
secondary male sex characteristics were well developed. 
This study was undertaken to determine if M. caroli has a localized 
qualitative or quantitative defect in renal androgen receptors or if the renal 
androgen-responsive endpoints differ from those of M. musculus. Since the 
fertility and sexual behavior of both male and female M. caroli appeared to be 
normal, the brain was considered to have normal androgen responsiveness and 
was used as a control tissue. Androgen receptors in brain and kidney from M. 
caroli and M. musculus were compared by several parameters. Renal 
androgen responsiveness of the two strains was evaluated using ornithine 
decarboxylase enzyme activity (ODC) as a third endpoint (Bullock, 1983; 
Grahn et al., 1973; Henningsson et al., 1978; Seely et al., 1982). 
MATERIALS AND METHODS 
Adult female Л/, caroli were a gift of Dr. Verne Chapman (Roswell Park 
Memorial Institute, Buffalo, New York). M. musculus (C57BL/6J female 
mice) were either purchased from the Jackson Laboratory (Bar Harbor, 
Maine) or bred in the colony at Children's Hospital, Boston. Mice were 
housed in a controlled environment with a 12-hr light-dark cycle, with food 
and water available ad libitum. In some mice a 30-mg testosterone pellet was 
implanted subcutaneously in the nape of the neck under light ether anesthesia 
to provide continuous androgen treatment. 
The concentration and affinity for testosterone of renal androgen recep­
tors were determined as described previously using [}H]testosterone (48 
Ci/mmol, New England Nuclear), DEAE-cellulose filters (DE-81, What­
man) to separate bound from free steroid, and Scatchard analysis (Bullock et 
al., 1978). /3-Glucuronidase activity was determined with a fluorometric assay 
using 4-methylumbelliferyl-/3-D-giucuronide (Research Products Interna­
tional Corp., Elk Grove Village, 111.) as substrate (Lusis et al., 1976). 
Ornithine aecarboxylase activity was quantitated by the determination of 
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,4C02 released from [''CJornithine (50 mCi/mmol, New England Nuclear) 
(Bullock, 1983). DNA-cellulose chromatography of androgen receptors in 
kidney and brain was performed as before (Wieland and Fox, 1979, 1982) 
except for the following changes: the extract buffer consisted of 50 т м 
Tris-HCl (pH 8.1,2ГС), 10 т м 2-mercaptoethanol, 1 т м Naj EDTA, 10% 
(v/v) glycerol, and 10 т м NaCl. Extracts, labeled with 10 пм [3H]dihydro-
testosterone (143 Ci/mmol), were loaded on columns of DNA-cellulose and 
incubated for 1 hr at 2ГС. The columns were then incubated for 0.5 hr at 
20C, washed in extract buffer, and eluted with buffer containing a linear 
gradient of 10-350 т м NaCl. 
RESULTS 
In the initial analysis of androgen receptors using DEAE-cellulose filters, 
receptors in kidney cytosol from Af. caroli and M. musculus had similar 
affinities for testosterone and were present at similar concentrations (Л/. 
caroli vs. M. musculus: К
л
 - 4.7 vs 2.3 χ 10"' м; sites - 41 vs 28 fmol/mg 
protein). This had not been expected in view of the absence of evidence of a 
response to testosterone in kidney weight and ^-glucuronidase activity in M. 
caroli. Two possible explanations were considered. First, qualitative differ­
ences in the androgen receptor that were not detected by this assay might 
result in the apparent androgen unresponsiveness in M. caroli. Second, a 
partial or different set of genes might be androgen responsive in M. caroli as 
compared to M. musculus. 
To explore the first possibility the qualitative and quantitative aspects of 
these receptors were evaluated by a second method. The chromatographic 
behaviors of brain and renal receptors from M. caroli and M. musculus were 
analyzed on columns of DNA-cellulose. Both the concentration and the 
elution pattern of androgen receptors from the brains of both species were 
similar (Fig. 1). Likewise, androgen receptors from kidney of M. caroli 
adhered to DNA-cellulose and were eluted by an increasing salt concentration 
in a similar pattern as the receptors from Af. musculus (Fig. 1). However, in 
repeated experiments with this method, the concentration of renal androgen 
receptor detected for Л/. caroli was only one-half to one-third that for M. 
musculus. This difference was not thought to be large enough to account for a 
complete renal insensitivity to androgen as suggested by the unresponsiveness 
of renal weight and ^-glucuronidase activity. 
Since both these species appeared to have adequate renal androgen 
receptors, we examined the possibility of a difference in renal androgen 
responsive genes. To evaluate a third endpoint of androgen response we 
assayed ODC activity. Renal weight and ^-glucuronidase activity were also 
monitored. Following 2 weeks of androgen treatment, there was no increase in 
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Fig. I. Elution of brain and kidney androgen receptors from 
DNA-cellulose. Cytosols from whole kidney (left) and brain (right) 
from M. caroli (filled symbols) and M, musculus (open symbols) 
were eluted with a linear NaCl concentration gradient from DNA-
cellulose columns. Initiai starting weights: brain, 0.38 and 0.41 g; 
kidney, 0.22 and 0.18 g (M. caroli and M. musculus. respectively). 
Cytosols were labeled with 10 пм [3H)dihydrotestosterone (143 
Ci/mmol). 
kidney weight or ^ -glucuronidase activity in Л/. caroli, while there was a 20% 
and 31-fold increase, respectively, in these parameters in C57BL/6J mice 
(Table I). In contrast, ODC activity increased markedly in both strains after 
only 5 days of treatment (Table I). 
DISCUSSION 
A number of different endpoints in the kidney of M. musculus have been 
shown to be androgen sensitive and their activities may increase two- to 
several hundred-fold in response to androgen treatment (Finlayson et al.. 
1968;Kochakianeía/.. 1948;Ohnoer al.. 1970; Schwarzlose and Heim, 1973; 
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Table I. Renal Response to Testosterone" 
Weight (mg) 
^-Glucuronidase' 
Ornithine 
decarboxylase* 
M. caroli 
Control 
278 ± 14 
6.8 ± 0.3 
0.32 ± 0.02 
Testosterone 
283 ± 11 
7.1 ±0.9 
208 ± 26 
M. 
Control 
257 ± 12 
7.2 г 0.1 
0.2 ± 0.03 
musculus 
Testosterone 
308 ± 13 
224 ± 8 
142 ± 6.7 
'Treated female M. caroli or M. musculus (C57BL/6J) mice were killed 14 days (kidney weight. 
^-glucuronidase activity) or 5 days (ornithine decarboxylase activity) after the subcutaneous 
implantation of a testosterone pellet (30 mg). 
'^-Glucuronidase, fimol/hr/gm kidney; ornithine decarboxylase, nmol'4 COj/mg protein/30 
mm. 
Swank et al., 1978). The initial report of an apparent absence of androgen 
responsiveness in the kidneys of another murine species. M. caroli, was thus 
provocative. Determination of the genetic factors responsible for this differ­
ence would add to the understanding of the genetic control of androgen action. 
The unresponsiveness was apparently not associated with a bodywide 
androgen insensitivity due to a lack of androgen receptors since males had 
fully developed male genitalia and were fertile. Other considerations included 
the possibility that the gene(s) coding for androgen receptors was not 
expressed in the kidney so that the organ itself was androgen insensitive, an 
alteration in the renal androgen receptor such that it was no longer biologi­
cally active in the kidney, and a change in gene regulation such that only a 
partial or perhaps completely different family of genes was activated by 
androgens in M. caroli as compared to Λ/, musculus. 
The results of our initial study, which documented the presence of 
androgen receptors in kidneys of M. caroli with a comparable concentration 
and affinity for testosterone as in Λ/, musculus, excluded the possibility that 
the reported lack of response of renal weight and /^-glucuronidase activity was 
associated with an absence of renal androgen receptors. The receptors in Λ/. 
caroli were subsequently shown to have biochemical characteristics qualita­
tively similar to those in M. musculus. We cannot account for the difference 
in receptor concentration in the two species that was detected by DNA-
cellulose chromatography as compared to similar concentrations determined 
by DEAE-cellulose and Scatchard analysis. It may be due to different 
requirements for DNA binding between the two species, different degrees of 
receptor activation, or differences in receptor degradation in vitro. Whatever 
the reason, the difference in concentration was not thought to be significant 
enough to result in the renal androgen insensitivity ascribed to M. caroli. 
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Since it was likely that the renal androgen receptor detected in M. caroli 
was biologically active, it was probable that the dichotomy in androgen 
response between species was due to a difference in the regulation of the 
response at the level of regulatory elements associated with individual genes 
and that we had not been monitoring the most relevant endpotnts. An increase 
in ODC activity in response to androgen in M. caroli that was similar to that 
in M. musculus supported this hypothesis. While this study was in progress 
the concentrations of some specific mRNAs, including that for ODC (Berger 
et al., 1984), were reported to be increased in kidneys of both M. caroli and M. 
musculus by androgen treatment. In contrast, other mRNA's were inducible 
in only M. musculus (Berger, personal communication). This is further 
evidence that the regulation of renal androgen responses is different in the two 
species. 
The control of androgen-responsive genes is known to be complex, 
involving steroid metabolism, receptor activity, other hormones, and regula­
tory DNA sequences (Bardin and Catterall, 1981; Wilson et al.. 1981). 
Species differences in androgen responses of similar tissues and genes provide 
useful probes for further in-depth study of the respective roles of these various 
factors. In view of the recent use of renal ODC (Berger et al., 1984, 1986; 
Kontula et al., 1984, 1985; McConlogue et al., 1984) and ^-glucuronidase 
(Catterall and Leary, 1983; Palmers/ al.. 1983) genes and their regulation by 
androgen in M. musculus to elucidate steroid regulation of gene expression, 
parallel studies in M. caroli should be informative. 
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ABSTRACT 
Tfi*·»0. a ne* occurrence of the Z-linked mutation testicular feminization. 
has been isolated in a stock of mica and mapped to the same region as the 
original Tim* mutation. Ve compared these two mutants to determine if there 
are differences in their putative residual androgen receptors or androgen 
responsiveness. Such differences have been reported for Tfm mutations in 
humans. We found no evidence for induction of ornithine decarboxylase (ODO 
activity in TfmLac despite androgen treatment for up to 3 weeks. This is m 
agreement with findings for Tfm'. Both of these mutants expressed small 
amounts of androgen binding activity which shared some properties with the 
normal androgen receptors m mouse kidney. The binding was distinguishable 
between the two mutants, however, as determined by hormone saturation 
experiments utilizing DNA-cellulose chromatography. These findings confirm the 
independence of the two mutations and are consistent with their being allelic: 
both result in severe deficits of androgen binding and response. 
Key words: androgen, androgen receptor, kidney, mice, testicular feminization 
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The testicular feainization (TCm) mutation, which results in androgen 
resistance and decreased phenotypie masculinization, has occurred in many 
maaaals including huaans, rats, and mice (Wilson and HacDonald, 1978; Griffin 
and Wilson, 1980; Fox et al., 1983; Bardin et al.. 1970; Stanley et al., 
1973; Lyon and Bavkes, 1970). Aaoog the several huaan syndromes of androgen 
resistance is a range of androgen sensitivity from profound androgen 
msensitivity to partial responsiveness (Amrhein et al., 1976; Kaufman et al, 
1977; Aiaan et al., 1979; Sriffin and Wilson, 1980). The tfm syndrome 
in rats falls on a point along the scale representing partial responsiveness 
(Fox et al., 1982), while the original mutation in mice, Tfm'• results in 
profound androgen resistance. Affected mice have X and Y chromosomes, but 
externally resemble females; internally, they lack a uterus, but possess 
primitive testes. 
The large nuaber of huaan cases, representing separate occurrences of the 
autation, has contributed greatly to our understanding of androgen action 
primarily through the diversity of distinguishable receptor defects. Although 
previously representing only two separate mutations, one each m rats and aice, 
the rodent mutants are also important as they serve as useful models for the 
huaan syndromes. Along with their normal littermates. they allow multiple 
tissues to be examined for the effects of androgens m vivo, developmental 
studies of the embryonic effects of androgens, and correlations of the effects 
of administered androaens with receptor properties and physiological and 
cellular responses. 
A new occurrence of testicular feminization in the mouse was reported by 
liovell in 1979 (Lovell. 1979). It is named nm L» c for Laboratory Animals 
SO 
Centre, HRC, to distinguish it tro» the original Tfa autant froa Harvell 
(Tfa*). This provided the opportunity to coapare two Tfa nutations within a 
single rodent species. Although the external phenotype of Tfa*·" was similar 
to Tfa*, it was hoped that the biocheaical basis for the defect would be 
different and thus expand the variety of defects available for study, siailar 
to what has occurred in huaans. 
λ preliainary study revealed differences in the characteristics of the 
residual androgen binding activities in Tfa*·"' and Tfa'. The data suggested 
that the receptor nutation for TfBL*c aice »as siailar to that for tfa rats, in 
which a reduced aaount of apparently noraal androgen receptor (Vieland and Fox, 
1981; Fox et al., 1983), and soae residual resipnsiveness (Krey et al., 1982; 
Hillard et al., 1986) have been described. This paper reports on a further 
coapanson of androgen receptor binding activities of Tfa*·" and Tfa" on 
DNA-cellulose and on an evaluation of androgen responsiveness of Tfa 1·" using 
renal ornithine decarboxylase (ODO activity, a sensitive indicator ot androgen 
action (Bullock, 1983; Houben et al., 1986). 
MATERIALS AND HETBODS 
TfoLtc
 и а і
 b
r e
4
 l n imkage with tabby (Ta), which aids in identifying 
affected autants. These are designated as Tfa1··1 Ta / Y or TfB L , e. Tfa' was 
bred in balance with Ta: these autants are designated as Tfa' + / Y or Tfm*. 
Original stocks of Tfm* and Ta mice were provided by Dr. Eva Eicher, The 
Jackson Laboratory, Bar Harbor. Me. Animals (60-150 days old) were age matched 
between mutant and litteraate groups. For receptor studies, mice were 
castrated two weeks prior to use. Animals were killed by cervical dislocation 
a ι 
followed by immediate removal and cleaning of the kidneys. 
To evaluate the response of renal (ODO activity to androgen treatment, 
Tfm1·" and normal female mice were treated with testosterone by three different 
protocols: testosterone pellets (30 mg) were implanted subcutaneously in the 
nape of the neck under light anesthesia 5 days or Ì weeks prior to sacrifice, 
or 1 ag testosterone was injected daily for 7 days. Responses in the normal 
range for C57BL/6J females were obtained in preliminary experiments with 
litternate feaales from the Tfm stocks. Since these levels varied, presumably 
caused by heterozygosity, C57BL/6J females were used in the experiments 
reported here to ensure a positive control for the assay. ODC activity was 
determined as reported earlier (Loeb et al.. 1984). Briefly, kidneys were 
minced, and homogenized with a Polytron tissue disruptor (Brinkman Instruments. 
Weetbury, HY) for 5 sec in 1.5-4.0 ml of ice-cold buffer (25 mM Tns-HCl. 
pB 7.4 at 22'С 0.1 mH EDTA, 2.5 mM DTT). The tissue homogenate was 
centrifugad at IS.OOOXg for 10 m m at 4*C. The supernatant was diluted 
appropriately with buffer and ODC activity was determined by the quantitation 
of ««CO» released from [l-14C]ornithine (Pegg and McGill, 1979). The reaction 
was stopped with 5 N BiSO«. Radioactivity was determined in a scintillation 
counter in 10 ml of toluene-based scintillation fluid. Protein concentration 
was determined by the method of Lowry et al. (1951) using BSA as standard. 
Activity was expressed as pmoles COi released/mg protein/30 mm. 
For analysis of renal androgen receptors, DNA-cellulose chromatography was 
performed as described previously (Uieland and Fox, 1979; Fox and Savakis, 
1983). Extract and elution buffer contained 50 mH Tns-HCl, pH 8.1 (21»C) 
1 mM ¿-aercaptoethanol. 1 mM NajEDTA. 10% glycerol, and 10 mH NaCl; Che 
molarity of NaCl during chromatography is indicated below and m the figure. 
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The ionic strength of extracts and buffers was aonitored by aeasunng 
conductivity. All steps were carried out at 2*C. Bonogenates were prepared 
with Teflon/glass Duali hoaogenizers (Rentes) and then were eentnfuged at 
40,000 rpa for 45 nin (Becknan 70.1 Ti rotor). Supernatants of each genotype 
with coaparable protein contents were incubated with 10 nH, 20 nH, or 50 nH 
[l,2.4,5,6,7-'H(N)]-S-alpha-dihydrotesto3terone (['H]-DHT; 143 Ci/nnole,- New 
England Nuclear, Boston, HA) for 17 h and then chroaatographed through Sephadex 
ІЛ-20 (Rubin et al., 1986) to reaove unbound radioactivity. Saaples were 
loaded by gravity onto 3 al (packed voluae) coluans of DNA-eellulose, which had 
been equilibrated with buffer containing 10 mit NaCl; the samples were left in 
contact for 30 a m to optiaize binding to DNA. Since unbound radioactivity had 
been removed, elution was begun after washing loaded columns with elution 
buffer for only one hour. Saaples were eluted with a 12 ml linear gradient of 
NaCl (10-500 ntf) at a rate of б ml/hr and radioactivity in collected fractions 
was measured with a scintillation counter m a two-phase systea of Omnifluor 
(New England Nuclear, Boston, HA)-toluene. 
RESULTS 
Androgen induction of renal ODC activity was measured initially in 
Tta1·*' / Y mutants and female controls given Τ pellet implants for five days 
(Table I). As usual, ODC activity increased greatly in the androgen treated 
normal females. However, levels Cor treated mutants remained within the range 
of ODC activity seen in sham treated animals. To determine if longer exposure 
to Τ pellets or alternate administration of androgen by injection would result 
in some response in Tfm L a c
<
 ODC activity was measured in these additional 
S3 
groups of animais. Again no evidence of induction in the mutant was detected 
despite aarkedly increased OOC activity in treated female controls. 
In preliminary experiments to measure saturation of the residual androgen 
binding activity froa TimL*c. saturation had not been achieved by 
concentrations of ['HJ-DBT below 10 nH. This concentration is adequate for 
saturation of noraal androgen receptors (Fox, 1975). Accordingly, we prepared 
extracts of kidneys froa castrated mice, which then were labelled with 
concentrations of [,H]-0HT up to SO nH. Again, the binding activity in 
extracts froa Tfa L , c did not saturate. Instead bound radioactivity increased 
m proportion to the concentration of labelled DHT (Fig. 1). In contrast, 
binding activity in extracts from Tim1 was close to saturation with the lowest 
concentraten used. Soae further increase occurred between 20 nH and SO nH, but 
inspection of the elution profiles (Fig. 1) revealed that auch of the apparent 
increase in peak radioactivity was a result of rising background levels. 
Likewise, androgen binding from wild-type male extracts (+ + / Τ), labelled 
with 10 nH [Ή]-DHT bound 85% of the level of radioactivity obtained for 
extracts labelled with 20 nH; extracts labelled with 20 and 50 nH differed by 
only 4%. 
Since the animals used in these experiments were castrated and expressed the 
Ta autation, experiments were performed to control for these two factors. 
Similar results to those in Fig. 1 were obtained in parallel expenaents 
with extracts froa gonadally intact mice. When binding in intact and castrated 
mutants was compared, levels were within 10\ of each other, whereas only half 
as much binding was detected in intact vs castrated wild-type males. However, 
the degree of saturation by various concentrations of androgen was the same in 
mutant and castrated animals. As a control for a possible contribution of the 
34 
tabby phenotype to the result, »e tested the few Tfm1··' • / Y aniaals produced 
froa crossovers m the Boston colony. Qualitatively, elutioo profiles were the 
saa«, and levels of binding were within 10% m extracts froa the two stocks of 
Tta»·" aice. 
DISCUSSION 
λ second report of an occurrence of testicular feainization in aice (Lovell, 
1979) provided the opportunity to coapare the two autations in this species. 
Tfa1·'' arose on a stock of aice at the Laboratories Aniaal Centre 
which carried the two Z-chroaosoae autations. Tabby (Ta) and jiapy (j£). 
Linkage studies confiraad that TfaL*c is on the X-chroaosoae, as is Tfm1 (Lyon 
and Hawkes, 1970). Furtheraore, the recombination frequencies indicated that 
Tfa 1·" aapped close to Tfa*. Accordingly, these two autations could be 
allelic. Ve have deterained whether they result in similar deficits ia 
androgen binding and androgen responsiveness. 
Androgen responsiveness in both Tfm' and TtnL*c nice is greatly decreased. 
In Tfa*, there is no evidence of a phenotypic response to endogenous androgens 
(Lyon and Hawkes, 1970) nor is there response to high levels of exogenous 
androgens even when the sensitive endpoint of ornithine decarboxylase activity 
is used (Pajunen et al., 1982). It should be noted, however, that зове reports 
suggest that there may be partial or selective responses in Tfm' (Schenkein et 
al., 1974; Toole et al.. 1979; Catterall et al.. 1986). The results are 
consistent with a quantitative decrease in receptors m Tfm* as compared to 
wild-type males. 
Some, but not all. procedures qualitatively distinguish the residual 
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androgen receptors in Tfa* from the majority of receptors m normal animals. 
Tests of the sedimentation constant and ligand affinity of receptors in Tfm' 
kidney (Gehnng and Tomkins, 1974; Attardi and Ohno, 1974; Fox, 1975) and 
measurement of gel permeation, and OEAE-cellulose elution properties of 
receptor in Tfa1 brain (Attardi and Ohno, 1978) did not reveal differences from 
normal. Hovever, «e found that residual maeromolecular androgen-bmding 
activity from Tfm' elutes from DNA-cellulose columns like a subset of normal 
androgen receptor, distinguishable from the major eluting fraction (Vieland et 
al., 1978; Fox et al., 1978; Vieland and Fox 1979). This vas confirmed by 
isoelectric focusing (Fox and Vieland, 1981). In contrast, the elution 
profiles of the residual activity from Tfm1·*1' did not differ qualitatively from 
normal and accordingly were distinguishable from Tfm' (Fox et al., 1983). This 
suggested that Tfm1··' might possess a reduced amount of a possibly normal 
receptor; to challenge this hypothesis, we examined the ability of DHT to 
saturate this residual binding activity. 
To optimize quantitative comparisons of receptor binding, the present study 
used steeper elution gradients of ionic strength than before (Fox et al., 
1983), which consequently did not allow subtle qualitative comparisons of 
elution characteristics. We also modified the procedure to decrease the 
duration of ONA-cellulose chromatoqraphy. Typically, the extract is applied to 
the column after labelling, and then 12-16 hours of wash are required to remove 
unbound radioactivity prior to elution of receptors. This method gave 
consistent results with Tfm» receptors but variable amounts of androgen binding 
with extracts from Tfm1·"· mice. This suggested that Che androgen binding 
detected in extracts from Ttm*·*1 was less stable or had a much reduced affinity 
for androgen. To test these possibilities, labelled extracts were run through 
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columns of Sephadex LH-20 to remove unbound radioactive androgen prior to 
chromatography on DNA-cellulose, thus eliminating the lengthy wash. In this 
manner, consistent peaks of androgen binding were obtained and it was possible 
to test saturation of the putative residual receptor as a means of estimating 
androgen affinity. 
The results indicate that the residual androgen binding activity in Tfm1·*« 
exhibits the same DNA-binding properties as wild-type androgen receptor, but 
with altered androgen binding. Because at higher concentrations of [Ή]-DHT, 
minor impurities of the label began to interfere with detectability of specific 
binding, especially for the lo» levels of binding m the mutants, we did not 
test concentrations above 50 ntt. Thus, in these experiments, the residual 
activity in Tfm L , c was not saturated, although saturation of the residual 
activity from Tfm' and the normal receptor from controls was nearly complete at 
10 nH ['HJ-DHT. This is consistent with earlier experiments using Tfm" 
(Gahnng and Tornkms, 1974; Attardi and Ohno, 1974; Vieland and Fox, 1979). 
Also consistent with these results are our findings (data not shown) on 
blocking of 10 nn ['B]-DHT binding by 1 дН nonradioactive DHT. Inhibition was 
99% for control males, 95% for Tfm*, and 81% for Tfm 1·" • which is expected from 
our inability to saturate this genotype. The low affinity of this activity 
precluded a thorough analysis of its specificity and the level of its content. 
The mutations, Tfa* and Tfm1·*0 , both result in deficits in androgen 
responsiveness which are associated with defects m androgen binding. The 
distinctive elution pattern Crom DNA-cellulose for Tfm" indicates that this 
mutation causes a reduced level of receptor that may be either a minor form of 
wild-type receptor, or an abnormal protein. In contrast, the receptor in 
Tfm1·" has typical binding to DNA-cellulose, but greatly reduced affinity for 
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androgen. It is not certain that this binding activity is a mutated receptor; 
however, if it were a normal product normally masked by the presence of 
androgen receptor or elevated as a result of androgen resistance, it also 
should have appeared in Tim', but did not. It is plausible from this analysis 
that the residual activities m these two mutants result from two different 
mutations m the gene(s) coding for androgen receptors. It remains to be shown 
if these differences in androgen receptors are reflected by differences m any 
cellular response to androgens. 
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Table I. 
Renal Ornithine Decarboxylase Activity in Tía1-*1 After Testosterone Treatnent* 
CxperiDcnt TfmL"e Females 
Τ pellet, 5 days 247 + 60° 96.900 + S300 
Controls * "182 + 25 263 + 40 
95 
86 
101 
113 
•f 
• 
+ 
+ 
во
6 
6 
9 
11 
13 
Τ pellet, 3 weeks +' 6 102,700 + 6200 
Controls 115 + 29 
Τ injections, 5 days 89.300 + 7500 
Controls 18 97 + 15 
Mutant TfmL«c males or normal females were treated for 5 days or 3 weeks with 
implants of Τ pellets or were injected with testosterone in oil daily for 5 
days. Sham implanted or oil injected mutants, respectively, were controls. 
b 
Ornithine decarboxylase activity is expressed as pmol ' «C-COj/ng protein/30 
•in • S.E.M. 
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Figur« 1. 
Saturation analysis by DNA-cellulose chromatography oí androgen binding 
activities in kidney extracts iron castrated TfnL>c (9.6 mg soluble protein), 
Тів' (11.S mg soluble protein), and littermate male (12.2 og soluble protein) 
Bice. Extracts of each genotype »ere labelled with 10 nH (-·*-), 20 nH (••o·-) 
or 50 nH (-·—> ('HJ-DHT prior to sequential Sephadex La-20 and DNA-cellulote 
chroaatography. The concentration of NaCI in the eluting buffer vas 
deterained by conductivity and is indicated (- — - - ) . 
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GENERAL DISCUSSION 
Understanding gene regulation is the basis for under­
standing life. We have been studying the regulation of 
steroid action, androgens In particular, as one approach to 
better understanding gene regulation. The final manifestation 
of steroid action involves β number of steps: the steroid 
enters the cell where it may be metabolized or not; it then 
may bind to receptors belonging to one or more steroid 
classes; the steroid-receptor complex binds to specific 
acceptor sites on chromatin resulting in the transcription of 
specific genes and ultimately in the biological expression 
appropriate for the tissue and the type(s) of steroid 
represented by the compound. The best understanding of each 
of these steps comes through the study of different variables 
involved in the regulation or manifestation of each of these 
steps. Studies reviewed in this thesis and the presented 
studies allowed us to gain more insight into the above 
mentioned steps and provide data leading to a better under­
standing of the mechanism involved or to develop further new 
models that can be used in future studies in this area. 
In our laboratory the study of androgen action in mouse 
kidney has been the central theme for several years. The 
kidney in Mus musculus, the common laboratory mouse, is an 
excellent organ for this research. Multiple androgen respons­
ive end points are present and some, especially B-glucuroni-
dase activity, have been characterized extensively. Several 
inbred strains of mice with different alleles regulating 
androgen action are available for comparison. Many aspects of 
the intracellular androgen response have been characterized 
and have been shown to be similar to those of androgen 
responsive secondary sex tissue. A further advantage is that 
the absence of 5a-reductase activity means that there is no 
metabolism of Τ in this organ. 
Our laboratory chose to use various progestins in the 
study of androgen action as they were known to have andro-
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genie, anti-androgenic, and potentiating effects on some 
forms of androgen action (Mowszowicz et al. 1974; Bullock et 
al. 1978). Each class of steroid hormone appears to mediate 
its biological response by binding to a receptor protein that 
is confined to target tissues (Jensen and De Sombre, 1972). 
It had been shown that the androgenic actions of progestins 
were related to their binding to the androgen receptors 
(Brown et al. 1979). 
Subsequent characterization of androgen receptor by Brown's 
and bullock's group led to the observation that the andro­
genic-progestin 6MP, bind to the androgen receptor in mouse 
kidney, however it also binds to renal receptors in 
Tfm/Y mice, lacking effective androgen receptors. Since mouse 
lacks progestin receptor, this finding in Tfm/Y mice indicat­
ed that 6MP was also capable of binding to a second class of 
receptors. This led to the demonstration that 6MP also binds 
to a glucocorticoid receptor in mouse kidney and liver (See 
Ch. IV). The presence of such a receptor had not been 
previously reported for reported for kidney but has been well 
discribed for liver (OiSorbo et al. 1977). This finding is 
important since it must be considered in the interpretation 
of the in vivo data reported in chapter I1I-2, where we 
suggested another macromolecule involved in nuclear steroid 
uptake. The possibility that this binding may be involved in 
the potentiation by other steroids of nuclear uptake of 6MP 
should be investigated in the future. Also, as techniques 
improve, it will be of interest to compare receptor activ­
ation, chromatin interaction and stimulation of gene express­
ion by pure androgens, pure anti-androgens and by steroids 
such as 6MP that have been shown to have multiple bindings 
sites and effects. 
The importance of metabolism in determining the active 
form and thus the biological effects of the steroid has been 
recognized for some time. In prostate 5a-reductase activity 
is high and Τ is metabolized to DHT which is bound by the 
androgen receptor, concentrated in the nucleus, and consider­
ed to be the active androgen. In contrast, our laboratory had 
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shown that mouse kidney lacked 5a-reductase, was not meta­
bolized, and Τ was the active androgen. It was a surprise to 
find the 20a metabolite of 6MP in kidney nuclei since intra­
nuclear metabolites had not been detected for previous 
progestins. Significantly, there was no 20a metabolite in 
nuclei from prostate-seminal vesicle. This suggested that the 
single compound 6MP, might be bound to different receptors 
and/or have different biological effects in the two tissues. 
Lack of sufficient amounts of ^Η-metabolite prevented binding 
studies but the metabolic study showed the difference in 
intranuclear steroid to be due at least in part to a 
difference in metabolism between the two tissues (See Ch. 
V). There was little 20a-hydroxy steroid dehydrogenase 
activity in prostate-seminal vesicle. Future studies could 
benefit from this difference to study how different molecular 
and biological effects are manifested by a single steroid 
depending on the metabolic and receptor characteristics of 
different tissues. 
Within the nucleus, the steroid-receptor complex acts to 
activate specific genes. The genes that are activated may 
vary between tissues as well as between animals of different 
gens types. One of the major advantages of mouse kidney to 
study the differences in biological response and relative 
binding affinity, is the numerous androgen responsive genes 
and inbred mouse strains providing potential for study of 
androgen action on specific genes when under the control of 
different regulatory alleles. This advantage has been greatly 
enhanced by the current progress in molecular biology utiliz­
ing cONA, reconstructed genes, monoclonal antibodies, etc. 
Our laboratory characterized the very high and androgen 
specific response of OOC. These characteristics make ODC 
activity an ideal end point worthy of further characteriz­
ation and utilization of these newer techniques. Our 
demonstration of 2 forms of ODC, only one of which is andro­
gen responsive (See Ch. VI), correlates with the recent 
reports from several molecular biology laboratories of 2 or 
more genes for ODC. Our findings provide biological endpoints 
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for future studies at the molecular level of how similar 
genes are regulated, what is the difference between androgen 
receptor chromatin interaction between and active and 
unresponsive genes, etc. 
In studying gene regulation, it is helpful when the same 
gene can be studied in the same tissue under different allel­
ic regulation as is possible in studies of B-glucuronidase 
stimulation by androgen in different inbred strains of mice. 
Further characterization is needed but there is a suggestion 
that different genetic control may also exist between inbred 
strains in their androgen stimulated response of ODC. Another 
approach is to study the regulation of the same gene in 
similar tissues of different species. The potential for such 
an approach arose from the studies of the androgen response 
of the kidney in Mus musculus and Mus caroli. Because of the 
absence of androgen response in renal weight and S-glucuro-
nidase activity, the kidney of M. caroli was originially 
thought to represent a possible example of localized tissue 
unresponsiveness. However, the finding of renal androgen 
receptors and androgen stimulation of OOC activity (See Ch. 
VII) suggested that the genetic regulation of renal androgen 
response varied at the level of individual end points in the 
two species of mice. Comparison of androgen stimulation of 
both ODC and B-glucuronidase in M. musculus and ODC but not 
β-glucuronidase in M. caroli at the molecular level will add 
valuable information of factors regulating androgen 
stimulating gene expression. 
Another opportunity to study androgen regulation of gene 
expression came with the report of a second, X-linked 
mutation in an androgen insensitive mouse. The original Tfm/Y 
mouse, that lacks effective androgen receptors such that it 
has a body wide androgen insensitivity, has been important, 
as mentioned above, in detecting non-androgen receptor 
mediated events. It has also been important for the disection 
of androgen action at the molecular level for only when a 
step is missing and the normal response is halted is the 
necessity of a step proven. Several different mechanisms 
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involving receptor and post receptor events mediating andro-
gen responsiveness have been reported to be involved in 
androgen insensitive humans (Wilson et al. 1981). Thus the 
report of a second androgen insensitive mouse (Tfrn^/Y) was 
important since it could offer the opportunity to look at a 
second putative step in androgen action. We found that the 
new mutation also affected the androgen receptor (See Ch. 
VIII). Although the binder has several of the biochemical 
characteristics of the normal receptor its affinity for 
androgens was greatly reduced. In the original Tfm/Y the 
number of receptors are also reduced with only a fraction of 
a minor subset of normal receptors remaining. These 2 models 
can be compared in future studies at the molecular level to 
study the role of the androgen receptor conformation and DNA-
chromatin binding. 
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SUMMARY 
The overall goal of this study was to define further the 
hormonal and genetic factors that regulate steroid 
responses.Androgenic responses in mouse kidney were used as a 
model. 
Chapters I,II and III provide background material on the 
mouse kidney as an androgen target organ and on the effects 
of progestins on this tissue. Using this as a background, 
chapters IV- VIII report on the various studies done for this 
thesis to define further the mechanism and regulation action 
at the metabolic, receptor, nuclear and genetic levels. 
Chapter I; Mouse kidney as an androgen target organ. 
The mechanism of androgen action in mouse kidney, the mouse 
kidney as an androgen target organ, and the biological 
responses stimulated are reviewed. Although dihydro-
testosterone (DHT) is considered to be the active androgen in 
reproductive tract and skin, studies of in vivo and in vitro 
androgen metabolism in mouse kidney indicate that 
testosterone (T) per se initiates androgen action in this 
organ. There is little 5a-reductase activity in mouse kidney 
so Τ is not reduced to 5a-0HT. The binding of Τ and DHT to a 
common binding site in kidney cytosol has been confirmed and 
the characteristics of the kidney androgen receptor 
determined by in vitro studies using a variety of assays. 
In mouse kidney, androgens induce an increase in total 
protein and ribonucleic acid (RNA), but no change in deoxy­
ribonucleic acid (DNA) content, indicating that the increase 
in organ weight is associated with cellular hypertrophy 
rather than hyperplasia. In mouse kidney a number of well 
characterized, specific androgen stimulated endpoints have 
been identified. A great deal is also known about the genetic 
regulation of androgen stimulated fl-glucuronidase activity. 
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An important tool in the studies of the mechanism of androgen 
action described in this thesis has been the Tfm/Y (TfmH) 
mouse. An inherited defect causing an absence of effective 
androgen receptors, results in a body wide insensitivity to 
androgens. This mouse is thus helpful in studies to 
distinguish between specific and non-specific androgen 
receptor mediated and non-receptor mediated responses to 
steroids. 
Chapter II; Effects of progestins on mouse kidney. 
The literature on the effects of progestins on mouse kidney 
is reviewed. The progestins medroxyprogesterone acetate 
(MPA), megestrol acetate (MegAc) and 6a-methylprogesterone 
(6MP) stimulated androgen action on mouse kidney as evaluated 
by several endpoints. By contrast, in androgen insensitive 
Tfm/Y mice, MPA was ineffective in stimulating any of these 
androgenic responses. By itself, cyproterone acetate (CypAc) 
had no effect on mouse kidney, but when administered in 
approximately equal amounts with T, it enhanced the 
stimulation of θ-glucuronidase activity. When larger amounts 
of CypAc were used, its classic antiandrogenic effect was 
manifested. A similar synandrogenic stimulation of 
θ-glucuronidase activity was seen when DHT was used as the 
androgen, or when MPA, MegAc or 6MP were used as the 
progestins. 
Progestins have been shown to bind to the mouse kidney 
androgen receptor. In mouse kidney cytosol, Ή-ΜΡΑ was bound 
by a high affinity, low capacity macromolecule with 
characteristics similar to the androgen receptor. MPA, MegAc 
and CypAc compete with Τ for binding to this macromolecule. 
Following the intravenous administration of ^H-MPA, 
increasing concentrations of radioactivity accumulated in 
nuclei of kidney and could be blocked by androgens. ^Η-ΗΡΔ 
was not retained in nuclei of Tfm/Y mice lacking effective 
androgen receptors. 
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Chapter III: the effects of éa-methylprogesterone (6MP) on 
mouse kidney. 
The effects of a specific progestin, 6MP, on mouse kidney are 
reviewed. 6MP has androgenic, synandrogenic and antiandro-
genic effects on mouse kidney θ-glucuronidase and androgenic 
effects on prostate-seminal vesicle weight. It stimulated an 
increase in RNA polymerase I and II similar to that induced 
by androgens. It also stimulated an increase in renal RNA 
polymerase activity in Tfm/Y mice. This suggested that in 
kidney 6MP could be bound by another receptor besides the 
androgen receptor. 
In a series of in vivo studies using ^H-T and ^н-бМР, nuclear 
uptake in prostate-seminal vesicle was shown to have greater 
affinity for ^H-T while nuclear uptake in kidney was greatest 
for 5H-6MP. The addition of other steroids enhanced Ή-όΜΡ 
nuclear uptake in kidney but not prostate-seminal vesicle. 
When Tfm/Y mice were used, not only was there nuclear uptake 
of radioactivity, but it could be enhanced by the addition of 
6MP but not by T. There was no uptake by renal nuclei of 
^Н-Т, -MPA or -Progesterone in these animals. It was 
subsequently found that kidney nuclei contained 6MP and the 
20a-hydroxy metabolite of 6MP while only 6MP was concentrated 
in prostate-seminal vesicle nuclei. 
These data suggested that 6MP was bound by the androgen 
receptor and was responsible for the androgenic effects of 
the compound but that 6MP and the 20a-hydroxy metabolite 
could be bound by another receptor. 
Chapter IV: Studies of 6a-methyl progesterone in mouse 
kidney: characterization of receptor. 
As a progestin, 6MP is bound by the progesterone receptor. 
Previous studies indicated that, in mouse kidney, 6MP also 
had androgenic effects and was bound by the androgen receptor 
in mouse kidney and prostate-seminal vesicle. Additional data 
suggested that in kidney, 6MP was bound by a third receptor 
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in kidney. This paper reports on studies designed to 
characterize the third receptor. The results of in vitro 
studies of 'н-бМР binding in kidney and liver cytosol in 
normal and Tfm/Y mice indicated that 6MP was bound by a 
macromolecule with the characteristics of the glucocorticoid 
receptor. This provided further evidence that steroids may 
bind to multiple recptors which may vary between tissues. As 
a result, steroids can be expected to have multiple 
biological effects which will vary with the tissue depending 
on the class of receptors present. 
Chapter V; The differential regulation of the intranuclear 
progestin in mouse kidney and prostate-seminal vesicles. 
In earlier studies, 6MP and, to a greater extent, its 
20a-hydroxy metabolite were shown to be concentrated by renal 
nuclei following the administration of ^Н-бМР. In contrast, 
only 6MP was concentrated by prostate-seminal vesicle 
nuclei. The purpose of this study was to characterize the 
regulation of these two steroid species in these two 
tissues. The enzyme, 20e-hydroxy steroid dehydrogenase was 
shown to be present in kidney but not prostate-seminal 
vesicle cytosol. This illustrates the importance of the role 
of enzymes in determining the species of steroid available 
for receptor binding and thus the potential biological 
responses that can be elicited. 
Chapter VI; Two forms of ornithine decarboxylase activity in 
mouse kidney. 
To characterize the factors regulating steroid action it is 
important to have a sensitive endpoint and helpful if 
differences at the genomic level can be detected. The 
specificity and marked sensitivity of renal ODC to androgen 
stimulation had been shown previously. The present study was 
designed to characterize this response more carefully. Basal 
levels of ODC were shown to be consistent with two forms of 
ODC activity which differed in half-life, heat sensitivity, 
and androgen inducibility. 
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Androgens induced primarily the heat sensitive form and 
caused a marked increase in the overall half life of QDC 
activity in vivo. The androgen induced, heat-sensitive form 
decayed faster in vivo than did the heat-resistant form. It 
is not known of these responses represent changes in 
intracellular processing or the differential stimulation of 
two separate ODC genes. The two forms of ODC activity 
identified in this study provide endpoints that will be 
useful in future studies of androgen action at the genomic 
level. 
Chapter VII; Differences in androgen response between two 
mouse species. 
In a study of the factors regulating steroid action, the 
availability of mice with different responses to the same 
steroid in the same tissue is extremely useful. Renal weight 
and B-glucuronidase activity are two well-characterized 
androgen-responsive parameters in Mus musculus. In contrast, 
a similar response had not been found in Mus caroli, although 
the external genitalia were masculinized. This study was 
designed to determine if a localized defect in androgen 
receptors or a difference in renal androgen-responsive 
endpoints in the two species existed. Only small differences 
between the androgen receptors of the two species were 
detected and were not thought to account for the lack of 
response of renal weight and β-glucuronidase activity in Mus 
caroli. When a third renal endpoint , ODC activity, was 
analyzed in M. caroli, an androgen response was elicited. 
Thua differences in renal androgen response in these two 
mouse species differs not at the receptor level but at the 
level of genetic regulatory elements. They provide unique 
probes for studies of the regulation of androgen action at 
the genomic level. 
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Chapter VIII; Tfm^act a second isolation of testicular 
feminization in mice. 
The large number of human cases of androgen insensitivity, or 
testicular feminization, representing separate occurrences of 
the mutation, has contributed greatly to our understanding of 
androgen action, primarily through the diversity of 
distinguishable receptor and post-receptor defects. The 
occurrence of a second instance of testicular feminization in 
the mouse. Tfmlac, offered the potential to expand the 
diversity of defects resulting in androgen insensitivity in 
an animal model. The Tfrn^  mouse has a body-wide 
insensitivity to androgens associated with a major deficiency 
of androgen receptors with only a small amount of an abnormal 
androgen receptor remaining. It was hoped that the new 
nutation would have a different biochemical basis and thus 
expand the variety of defects in animals available for 
study. It was found, however, that, similar to TFM^, Tfmlac 
has an insensitivity to androgens that is associated with a 
major deficiency in androgen receptors. However, in contrast 
to TfmH, the residual receptors appear to be normal. It is 
possible that the Tfm^ac is a regulatory mutant while the 
TmfH represents a point mutation in the code for the 
androgen receptor. TfmH and Tfmlac mice should be useful in 
a variety of molecular studies to compare that portion of the 
X-chromosome coding for the androgen receptor, as an example 
of a regulatory mutant, and in studies to map areas of the 
receptor necessary for interaction with regulatory DNA 
elements and the elicitation of biological responses. 
This thesis thus provides additional information toward the 
understanding of the various ways by which steroid action can 
be regulated as well as providing background data necessary 
for future studies at the molecular level. 
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SAMENVATTING 
Deze studie heeft als doel de biochemische en biologische 
mechanismen en controle van androgenen verder te omschrijven. 
De hormonale en genetische factoren die de steroid respons 
reguleren worden nader onderzocht. Als model werd de andro­
gene actie in de nier van de muis gebruikt. 
In de Hoofdstukken I, II en III wordt een literatuuroverzicht 
gegeven over de muizennler als androgeen doelorgaan en van 
haar reactie op progestagenen. De artikelen, in de hoofdstuk­
ken IV t/m VIII, zijn studies over de werkings- en controle 
mchanismen van de steroidactie, waarbij celkernen, recepto­
ren, metabole en genetische aspecten aan bod komen. 
In hoofdstuk I wordt met name ingegaan op enkele factoren, 
die de nier van de muis als model geschikt maken voor onder­
zoek naar het mechamisme van androgene actie. Hoewel dihydro-
testosterone (DHT) beschouwd kan worden als een actief andro­
geen in het voortplantingsstelsel en de huid, hebben in vivo 
en in vitro studies aangetoond, dat in de muizennler het 
testosteron (T) verantwoordelijk is voor de androgene actie. 
Er is slechts weinig 5-alfa-reductase activiteit in de 
muizennler, zodat Τ niet wordt omgezet tot 5-alfa-DHT. De 
binding van Τ en DHT op eenzelfde bindingsplaats (androgeen-
receptor) is aangetoond. Eveneens werden de kenmerken van de 
androgeen receptor vastgelegd door gebruik te maken van 
verscheidene assays in vitro. Androgenen induceren een 
toename van het totale proteine, en ribonucleine zuurgehalte 
(RNA) in de muizennier, maar geen veranderingen in het 
deoxyribonucleine zuur (DNA) gehalte. Hieruit mag 
geconcludeerd worden, dat de gewichtstoename in dit orgaan, 
eerder een cellulaire hypertrophie dan een hyperplasie is. 
Een aantal goed gekarakteriseerde effecten van de androgene 
stimulatie in de muizennier zijn geïdentificeerd. Veel weet 
men reeds over de genetische regulatie van androgeen gestimu-
leerde fl-glucuronidase activiteit. 
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Een aangeboren defect in de Tfm/y (TfmH: testiculaire 
féminisâtie) muis veroorzaakt een algehele ongevoeligheid 
voor androgenen door het ontbreken van effectieve androgeen 
receptoren. Deze muis is daarom een belangrijk hulpmiddel in 
de studies ter verkrijging van een beter inzicht tussen de 
steroid respons via een specifiek en non-specifiek androgeen 
receptor en een respons zonder receptor. 
In hoofdstuk II wordt de literatuur die betrekking heeft op 
het effect van progestagenen op de muizennier besproken. De 
progestagenen medroxyprogesteronacetaat (MPA), megestrol-
acetaat (MegAc) en 6-alfa-methylprogesteron (6MP) stimuleren 
androgene actie in de nier van de muis zoals blijkt uit de 
syntheses van verscheidene specifieke proteïnen. In de Tfm/y 
muis bleek MPA daarentegen niet effectief te zijn. 
Cyproteron acetaat (CypAc) alleen liet geen effect op de 
muizennier zien, terwijl CypAc, toegediend tezamen met Τ in 
gelijke hoeveelheden daarentegen, de stimulatie van θ-glucu-
ronidase activiteit vergroot. Wanneer grotere hoeveelheden 
CypAc werden gebruikt dan kan men zelfs een antiandrogeen 
effect vaststellen. Dezelfde synandrogene stimulatie van 
B-glucuronidase activiteit werd gezien wanneer DHT werd 
gebruikt als androgeen of wanneer de progestagenen MPA, MegAc 
of 6MP toegepast werden. 
Studies tonen aan dat progestagenen zich binden aan de 
androgene receptor in de muizennier. 3H-MPA bindt zich in het 
cytoplasme van de muizennier met een hoge affiniteit en een 
lage capaciteit aan een macromolecuul dat karakteristieken 
vertoont gelijk aan een androgene receptor. MPA, MegAc en 
CypAc gaan een competitie aan met Τ voor een binding aan deze 
macromolecuul. Toediening van 3H-MPA i.v. laat een stijging 
zien van radio-activiteit in de celkernen van de nier. Dit 
effect wordt geblokkeerd door androgenen. 3H-MPA wordt niet 
teruggevonden in de kernen van Tfm/y muizen, en dit moet 
toegeschreven worden aan de afwezigheid van androgene recep­
toren bij deze muizensoort. 
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In hoofdstuk III wordt een beschrijving gegeven van de effec-
ten van 6-alfa-methylprogesteron (6MP) op de nier van de 
muis. 6MP heeft een androgeen, synandrogeen en anti-androgeen 
effect op de B-glucuronidase activiteit in de muizennier, en 
een androgeen effect op het gewicht van de prostaat en 
vesícula seminalis. Eveneens stimuleert het een stijging van 
de RNA polymerase I en II activiteit op gelijke wijze als 
door androgenen. Het idee, dat 6MP in de nier ook wel eens 
aan een andere receptor, dan de androgene receptor gebonden 
kan worden, kwam voort uit de vaststelling dat 6MP een 
stijging van renale RNA polymerase activiteit liet zien in 
de Tfm/y muis. 
In vivo studies laten zien, dat de opname van 3H-T en 3H-6MP 
in de kernen van de prostaat en vesícula seminalis een 
grotere affiniteit heeft voor 3H-T, terwijl in de nier 3H-6MP 
dat heeft. De toevoeging van een ander steroid liet een 
toename zien van 3H-6MP in de kern van de nier maar niet in 
die van de prostaat en vesícula seminalis. Wanneer de Tfm/y 
muizen werden gebruikt, zag men niet alleen een opname van 
3H-6MP in de kern, maar ook kon deze opname vergroot worden 
door de toevoeging van 6MP. Oit in duidelijke tegenstelling 
tot de toevoeging van T, die geen toename van 3H-6MP opname 
in de kernen van de Tfm/y muis liet zien. Eveneens was geen 
opname aantoonbaar van 3H-T, 3H-MPA of 3H-Progesteron. 
Ook werd vastgelegd dat de kernen van de niercellen, 6MP en 
een 20-hydroxy metaboliet van 6MP bevatten, terwijl in de 
prostaat en de vesícula seminalis alleen 6MP werd terug 
gevonden. 
Deze gegevens kunnen het best verklaard worden door aan te 
nemen dat 6MP zijn werk uitoefent via twee verschillende 
receptoren en wel a) de androgene receptor en b) via een nog 
niet gekarakteriseerde andere receptor. 
Hoofdstuk IV geeft de resultaten weer van het zoeken naar die 
"andere" receptor. 6MP bindt zich aan de progesteron receptor 
(progestagene werking). 
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De literatuur geeft weer dat 6MP eveneens androgene effecten 
heeft en zich kan binden aan een androgene receptor in de 
nier van de muia. Dit gegeven en ondermeer de bevindingen in 
de Tfm/y muia suggereren een binding van 6MP aan een derde 
receptor. De resultaten van de in vitro studies van 3H-6MP 
binding in de cytosol van de nier en lever in normale en 
Tfm/y muizen tonen aan dat 6MP zich ook bindt aan een macro-
molecuul met de karakteristieken van een glucocorticoide 
receptor. Deze resultaten zijn in overeenstemming met de 
veronderstelling, dat Steroiden zich kunnen binden aan 
verschillende receptoren. Hieruit volgt dat Steroiden 
multipele biologische effecten kunnen hebben die verschillen 
in diverse weefsels, afhankelijk van de daar aanwezige recep-
toren. 
Hoofdstuk V vermeldt de resultaten van een studie die een 
verklaring zoekt naar het verschil van intranucleaire 6MP en 
20-alfa-hydroxy-6MP gehalte in respectievelijk de prostaat en 
vesícula seminalis en de muizennier. 
6MP en vooral zijn 20-alfa-hydroxy metaboliet, blijken zich 
in de renale kernen te concentreren na toediening van 6MP. In 
de kernen van de prostaat en vesícula seminalis daarentegen 
kan alleen 6MP teruggevonden worden. 
Het enzym, ZO-alfa-hydroxy-steroid dehydrogenase is aanwezig 
in de nier, maar niet in het cytosol van de prostaat en de 
vesícula seminalis. Dit illustreert, hoe belangrijk de rol 
van enzymen is bij het bepalen van het soort steroid, dat 
beschikbaar is voor receptor binding en op die manier het 
vaststellen van de potentiële biologische respons die ontlokt 
kan worden. 
In hoofdstuk VI worden twee vormen van ornithine decarboxy-
lase activiteit onder gestandaardiseerde condities in de nier 
van de muis nader bestudeerd. Het is van belang de factoren, 
die steroidactiviteit reguleren beter te karakteriseren. Een 
gevoelig meetpunt (eindpunt), maar ook verschillen op 
genetisch niveau zijn belangrijke hulpmiddelen. 
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Eerdere studies demonstreerden een kwantitatief grote en 
snelle respons van ODC activiteit op androgenen. Deze studie, 
werd overwogen om de respons van ODC uitvoeriger te 
beschrijven. Basale ODC activiteit in de nier van een normale 
vrouwelijke muis blijkt te bestaan uit 2 vormen met verschil-
len in temperatuursgevoeligheid, halfwaardetijd en androgeen 
inductiegevoeligheid. 
Androgenen induceren in hoofdzaak de temperatuursongevoelige 
vorm en veroorzaken een forse toename in de halfwaarde tijd 
van ODC activiteit in vivo. De androgeen geïnduceerde tempe-
ratuursgevoelige vorm verliest sneller haar enzymactiviteit 
in vivo dan de temperatuurs ongevoelige vorm. Het is niet 
bekend of deze respons een verandering in het intracellulair 
verloop vertegenwoordigt of een verschil in stimulering van 2 
aparte ODC genen. Met de twee vormen van ODC activiteit, in 
deze studie verder beschreven, worden bouwstenen aangebracht 
voor toekomstige studies van androgene activiteit op 
genetisch niveau. 
Uiteindelijk bindt zich het steroid of gemataboliseerde 
steroid receptorcomplex aan "nuclear acceptor sites" (DNA 
acceptor sites). Dat enerzijds receptoren in verschillende 
diersoorten functioneel gelijk zijn en dat anderszijds de 
respons in verschillende cellen met dezelfde genen samenstel-
ling niet hetzelfde is, zou kunnen impliceren dat het type 
van respons vast ligt op de "acceptor sites" in de kern. Om 
dit verder te onderzoeken werden twee studies verricht 
(hoofdstuk VII en VIII). 
Hoofdstuk VII handelt over verschillen in androgene respons 
in twee verschillende muistypen met gelijke androgene recep-
toren in gelijke organen. 
Het gewicht van- en de B-glucuronidase activiteit in de nier 
zijn twee goed bekende androgeen-responsieve parameters in 
Mus musculus. 
In tegenstelling tot de Mus musculus kon in de Mus caroli 
eenzelfde androgenen respons niet gevonden worden ofschoon de 
externe genitalia gemasculiniseerd waren. 
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Deze studie werd gedaan met. als doel te bepalen of het een 
locaal defect in de androgene receptor betreft of een 
verschil in renale androgeen-responsieve "endpoints" in de 
twee muissoorten. Slechts een klein verschil in androgene 
receptoren kan gedetecteerd worden, wat niet verantwoordelijk 
kan zijn voor het gemis van respons in de Mus caroli. De ODC 
activiteit in de nier van de Mus caroli laat echter wel een 
duidelijke androgene respons zien. 
Geconcludeerd kan worden dat het verschil in renale androgene 
respons niet op receptor- maar op genetisch niveau gezocht 
moet worden. Genen geassocieerd met renale hypertrophie en 
θ-glucuronidase activiteit in Mus caroli, hebben in tegen­
stelling tot de androgene respons in Mus musculus hierop geen 
invloed. 
In hoofdstuk VIII wordt TfmLAC beschreven, die kenmerken 
hebben van een Tfm-muis. Bij de reguliere Tfm^ muis wordt 
het klinisch beeld verklaard door een vermindering van andro­
gene receptoren en het feit dat de resterende receptoren niet 
de karakteristieken hebben van een normale androgeenrecep-
tor. De Tfm'-™' muis heeft eveneens een gebrek aan androgene 
receptoren, doch de nog aanwezigen hebben wel karakteristieke 
kenmerken van een androgeenreceptor. 
Het is mogelijk dat de Tfm1- een toevallige mutant is, 
terwijl de TfmH een meer algemeen defect is. Moleculaire 
studies op dat stukje van het X-chromosoom waar de code van 
de androgene receptor gelocaliseerd is, zou zeer waardevol 
zijn om dit vraagstuk op te lossen. 
Deze thesis levert een verdere bijdrage in ons begrijpen, hoe 
Steroiden via verschillende regulatie- en werkingsmechanis­
men, processen op cellulair niveau sturen. 
Ook werden gegevens aangedragen, die als basis kunnen dienen 
voor verdere studies op moneculair niveau omtrent de werking 
van de Steroiden. 
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Stellingen 
behorend bij het proefschrift 
Further characterization of the 
mechanism and regulation of 
androgen action at the biological 
and biochemical level. 
P. W. H. Houben 
I 
6-alpha-Methyl-Progesterone bindt zich aan meer dan één 
receptor in de nier van de muis 
(Dtt proefschrift) 
II 
De biologische respons van androgenen is bijzonder complex 
waarbij steroid metabolisme, receptor activiteit, andere 
Steroiden en DNA-sequentie betrokken zijn 
(Dü proef schrift) 
III 
De stabiliteit van de progesteron receptor in mamma 
carcinoom onder ingevroren condities verschilt met die van 
het endometrium carcinoom 
(P G Satyaswaroop, 1982, met çepubliceerde studie) 
IV 
De onbetrouwbaarheid van de receptormeting is recht even-
redig met de heterogeniteit van het endomctnumcarcinoom 
(R Mortel et al, Chemotherapy of Gynecologic Cancer, 1984, 
125 - 138) 
V 
De inductie van de oestradiol-dehydrogenase activiteit door 
progesteron is een "receptor-mediated" fenomeen 
(Ρ G Satyaswaroop and R Mortel, Cancer Research, 1982, 42) 
VI 
Het slaappatroon kan van invloed zijn op de spermatogenesis 
(R Bots et al, 1988, geaccepteerd voor publikatie in Europ J Obstet 
Gynecol Reprod Biol ) 
VII 
Met een stethophoon luistert men en denkt daarbij aan wat 
een stethoscoop zou zien 
Vi l i 
Zowel de medicus als het econometrisch model kunnen 
diagnoses en prognoses stellen 
IX 
Medisch onderzoek wordt ondermeer gesteund door het voor-
schrijven van merk-preparaten 
X 
Een gynaecologisch onderzoek met één vinger geeft ver-
trouwen en kan evenveel informatie opleveren 
XI 
Het ondernemende van een Nederlander is zondags meetbaar 
tussen Meer en Antwerpen 
XII 
Placebo is als een kameleon hij kan alle gedaantes aannemen 
van een farmaceutisch middel 
XIII 
" T h e secret of being a bore is to tell everything " 
(François Voltaire, 1694 - 1778) 



